1 | Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade. (Choby G, Geltzeiler M, Almeida JP, Champagne PO, Chan E, Ciporen J, Chaskes MB, Fernandez-Miranda J, Gardner P, Hwang P, Ji KSY, Kalyvas A, Kong KA, McMillan R, Nayak J, O'Byrne J, Patel C, Patel Z, Peris Celda M, Pinheiro-Neto C, Sanusi O, Snyderman C, Thorp BD, Van Gompel JJ, Young SC, Zenonos G, Zwagerman NT, Wang EW) JAMA Otolaryngol Head Neck Surg 2023 Sep 01;149(9):837-844 4 Citations |
1 | Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. (Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ) J Clin Oncol 2023 Oct 10;41(29):4643-4651 2 Citations |
2 | Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis. (SenthilKumar G, Kothari AN, Maduekwe UN, Fournier K, Abbott DE, Wilson GC, Patel SH, Greer J, Johnston F, Dineen SP, Powers BD, Baumgartner J, Veerapong J, Leiting J, Grotz TE, Maithel SK, Staley C, Raoof M, Lambert L, Lee A, Kim A, Cloyd JM, Mogal H) Ann Surg Oncol 2023 Sep;30(9):5743-5753 4 Citations |
4 | Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma. (Jones S, Henry V, Strong E, Sheriff SA, Wanat K, Kasprzak J, Clark M, Shukla M, Zenga J, Stadler M, Dzwierzynski W, Harker-Murray A, Young K, Kothari AN, Clarke CN) J Surg Res 2023 Jun;286:35-40 1 Citation |
1 | Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline. (Harkenrider MM, Abu-Rustum N, Albuquerque K, Bradfield L, Bradley K, Dolinar E, Doll CM, Elshaikh M, Frick MA, Gehrig PA, Han K, Hathout L, Jones E, Klopp A, Mourtada F, Suneja G, Wright AA, Yashar C, Erickson BA) Pract Radiat Oncol 2023;13(1):41-65 18 Citations |
1 | Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis. (Parekh A, Keller FG, McCarten KM, Kessel S, Cho S, Pei Q, Wu Y, Castellino SM, Constine LS, Schwartz CL, Hodgson D, Kelly KM, Hoppe BS) Blood 2022 Sep 08;140(10):1086-1093 3 Citations |
1 | Gallbladder carcinomas: review and updates on morphology, immunohistochemistry, and staging. (Lee W, Chandan VS) Hum Pathol 2023 Feb;132:149-157 1 Citation |
1 | Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study. (O'Cearbhaill RE, Pérez-Fidalgo JA, Monk BJ, Tusquets I, McCormick C, Fuentes J, Moore RG, Vulsteke C, Shahin MS, Forget F, Bradley WH, Hietanen S, O'Malley DM, Dørum A, Slomovitz BM, Baumann K, Selle F, Calvert PM, Artioli G, Levy T, Kumar A, Malinowska IA, Li Y, Gupta D, González-Martín A) Gynecol Oncol 2022 Jul;166(1):36-43 13 Citations |
1 | Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study. (Short SS, Kastenberg ZJ, Wei G, Bondoc A, Dasgupta R, Tiao GM, Watters E, Heaton TE, Lotakis D, La Quaglia MP, Murphy AJ, Davidoff AM, Mansfield SA, Langham MR, Lautz TB, Superina RA, Ott KC, Malek MM, Morgan KM, Kim ES, Zamora A, Lascano D, Roach J, Murphy JT, Rothstein DH, Vasudevan SA, Whitlock R, Lal DR, Hallis B, Bütter A, Baertschiger RM, Lapidus-Krol E, Putra J, Tracy ER, Aldrink JH, Apfeld J, Le HD, Park KY, Rich BS, Glick RD, Fialkowski EA, Utria AF, Meyers RL, Riehle KJ) Cancer 2022 Jul 15;128(14):2786-2795 4 Citations |
1 | Does Angiosarcoma of the Breast Need Nodal Staging? (Herb J, Maduekwe UN, Goel N, Rosenberger LH, Spanheimer PM) J Am Coll Surg 2022 May 01;234(5):774-782 |
1 | Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences. (Vujanić GM, Parsons LN, D'Hooghe E, Treece AL, Collini P, Perlman EJ) Histopathology 2022 Jun;80(7):1026-1037 12 Citations |
2 | Multimodality Imaging for the Staging of Pancreatic Cancer. (McKinney M, Griffin MO, Tolat PP) Surg Oncol Clin N Am 2021 Oct;30(4):621-637 5 Citations |
1 | Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. (Sokolova AO, Marshall CH, Lozano R, Gulati R, Ledet EM, De Sarkar N, Grivas P, Higano CS, Montgomery B, Nelson PS, Olmos D, Sokolov V, Schweizer MT, Yezefski TA, Yu EY, Paller CJ, Sartor O, Castro E, Antonarakis ES, Cheng HH) Prostate 2021 Dec;81(16):1382-1389 9 Citations |
1 | The Substantial Omission of Indicated Postoperative Radiotherapy in Patients With Advanced-Stage Oral Cancer in the US-A Call to Action. (Awan M, Akakpo KE, Shukla M, Graboyes EM, Pipkorn P, Puram SV, Zenga J) JAMA Otolaryngol Head Neck Surg 2021 Oct 01;147(10):907-909 3 Citations |
1 | GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study. (Thaker PH, Bradley WH, Leath CA 3rd, Gunderson Jackson C, Borys N, Anwer K, Musso L, Matsuzaki J, Bshara W, Odunsi K, Alvarez RD) Clin Cancer Res 2021 Oct 15;27(20):5536-5545 12 Citations |
1 | Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California. (Lonky NM, Xu L, Da Silva DM, Felix JC, Chao C) Am J Obstet Gynecol 2021 Dec;225(6):656.e1-656.e11 |
1 | Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. (Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, George S, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ) JAMA Oncol 2021 Aug 01;7(8):1225-1230 79 Citations |
1 | Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case Report. (Sheth H, Kumar P, Shreenivas A, Sambath J, Pragya R, Madre C, Athikari N, Khandare H, Peshattiwar V, Datar R, Limaye S) JCO Precis Oncol 2021;5 11 Citations |
1 | The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database. (Barrett TF, Mazul AL, Stepan KO, Wood CB, Paniello RC, Zevallos JP, Massa S, Jackson RS, Schmitt NC, Zenga J, Kang SY, Pipkorn P, Rich JT, Puram SV) Oral Oncol 2021 Jul;118:105330 2 Citations |
3 | The effect of reconstruction on positive margin rates in oral cancer: Using length of stay as a proxy measure for flap reconstruction in a national database. (Campbell DA, Pipkorn P, Divi V, Stadler M, Massey B, Campbell B, Richmon JD, Graboyes E, Puram S, Zenga J) Am J Otolaryngol 2021;42(5):103012 2 Citations |
2 | Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast. (Mehdi M, Kong AL, Frebault J, Huang S, Huang CC, Cortina CS) J Surg Res 2021 Aug;264:138-148 4 Citations |
1 | Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery. (Jackson RS, Stepan K, Bollig C, Sharma RK, Patel M, Massa S, Puram SV, Zevallos JP, Pipkorn P, Zenga J) Otolaryngol Head Neck Surg 2021 Nov;165(5):682-689 1 Citation |
1 | Pathologic nodal staging for clinically node negative soft tissue sarcoma of the extremities. (Maduekwe UN, Herb JN, Esther RJ, Kim HJ, Spanheimer PM) J Surg Oncol 2021 May;123(8):1792-1800 3 Citations |
1 | Surgical outcomes and survival rates of colon cancer in children and young adults. (Akinkuotu AC, Maduekwe UN, Hayes-Jordan A) Am J Surg 2021 Apr;221(4):718-724 9 Citations |
1 | Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522. (Awan MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan PF, Rosenthal DI, Schultz C, Huth BJ, Thorstad WL, Frank SJ, Kim H, Foote RL, Lango MN, Shenouda G, Suntharalingam M, Harris J, Zhang Q, Le QT, Yao M, NRG Oncology Group) Oral Oncol 2021 May;116:105241 5 Citations |
1 | Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes. (Esagian SM, Khaki AR, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Msaouel P, Koshkin VS, Grivas P) BJU Int 2021 Aug;128(2):196-205 19 Citations |
2 | Epidemiology and outcomes of primary pediatric lung malignancies: Updates from the SEER database. (Smith NJ, Mukherjee D, Wang Y, Brazauskas R, Nelson AA, Cortina CS) Am J Surg 2021 Oct;222(4):861-866 3 Citations |
1 | Concomitant MEK and Cyclin Gene Alterations: Implications for Response to Targeted Therapeutics. (Kato S, Adashek JJ, Shaya J, Okamura R, Jimenez RE, Lee S, Sicklick JK, Kurzrock R) Clin Cancer Res 2021 May 15;27(10):2792-2797 24 Citations |
1 | Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients? (Carter TM, Strassle PD, Ollila DW, Stitzenberg KB, Meyers MO, Maduekwe UN) Am J Surg 2021 Apr;221(4):706-711 8 Citations |
1 | Breast Implant-associated Anaplastic Large Cell Lymphoma. (Alotaibi S, Hamadani M, Al-Mansour M, Aljurf M) Clin Lymphoma Myeloma Leuk 2021 Mar;21(3):e272-e276 7 Citations |
1 | Breast Sentinel Lymph Node Frozen Section Practice: An Enterprise Audit as a Guide for Moving Forward. (Czaja R, Wu R, Jorns JM) Arch Pathol Lab Med 2021 Aug 01;145(8):1018-1024 6 Citations |
1 | Wilms Tumor: Challenges and Newcomers in Prognosis. (Parsons LN) Surg Pathol Clin 2020 Dec;13(4):683-693 4 Citations |
1 | New Prognostic Indicators in Pediatric Adrenal Tumors: Neuroblastoma and Adrenal Cortical Tumors, Can We Predict When These Will Behave Badly? (Jarzembowski JA) Surg Pathol Clin 2020 Dec;13(4):625-641 5 Citations |
1 | Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies. (Han L, Gallan AJ, Steinberg GD, Sweis RF, Paner GP) Hum Pathol 2020 Dec;106:54-61 4 Citations |
1 | The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Gynecol Oncol 2020 Dec;159(3):607-610 21 Citations |
1 | Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. (Emerson MA, Golightly YM, Aiello AE, Reeder-Hayes KE, Tan X, Maduekwe U, Johnson-Thompson M, Olshan AF, Troester MA) Cancer 2020 Nov 15;126(22):4957-4966 43 Citations |
1 | Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis. (Wrenn SM, Wang TS, Toumi A, Kiernan CM, Solórzano CC, Stephen AE) Am J Surg 2021 Feb;221(2):448-454 18 Citations |
1 | Yttrium-90 Portal Vein Radioembolization in Sprague-Dawley Rats: Dose-Dependent Imaging and Pathological Changes in Normal Liver. (Gordon AC, White SB, Gates VL, Li W, Procissi D, Zhang Z, Harris KR, Kim DH, Mouli SK, Omary RA, Salem R, Larson AC, Lewandowski RJ) Cardiovasc Intervent Radiol 2020 Dec;43(12):1925-1935 2 Citations |
1 | Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. (Yan F, Li H, Kaczmar JM, Sharma AK, Day TA, Neskey DM, Pipkorn P, Zenga J, Graboyes EM) JAMA Otolaryngol Head Neck Surg 2020 Dec 01;146(12):1109-1119 9 Citations |
1 | Utilization of Pelvic MRI for Nodal Staging in Rectal Cancer Staging. (Fair ES, Duvnjak P) Acad Radiol 2020 Dec;27(12):1718-1719 1 Citation |
1 | Choice of local therapy for young women with early-stage breast cancer who have young-aged children. (Pan IW, Yen TWF, Huo J, Chen C, Smith BD, Shih YT) Cancer 2020 Nov 01;126(21):4761-4769 |
1 | Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial. (DiSilvestro P, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian CA, Bradley WH, Mathews CA, Liu J, Lowe ES, Bloomfield R, Moore KN) J Clin Oncol 2020 Oct 20;38(30):3528-3537 62 Citations |
1 | Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer. (Aubry S, Strassle PD, Maduekwe U, Downs-Canner S) J Surg Res 2020 Dec;256:13-22 1 Citation |
1 | Swallowing Patterns in the HNC Population: Timing of Penetration-Aspiration Events and Residue. (Pisegna JM, Langmore SE, Meyer TK, Pauloski B) Otolaryngol Head Neck Surg 2020 Dec;163(6):1232-1239 9 Citations |
1 | A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients. (Saha G, Singh R, Mandal A, Das S, Chattopadhyay E, Panja P, Roy P, DeSarkar N, Gulati S, Ghatak S, Ghosh S, Banerjee S, Roy B, Ghosh S, Chaudhuri D, Arora N, Biswas NK, Sikdar N) Mol Med 2020 Jun 17;26(1):59 9 Citations |
1 | Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer. (Wainberg ZA, Hochster HS, Kim EJ, George B, Kaylan A, Chiorean EG, Waterhouse DM, Guiterrez M, Parikh A, Jain R, Carrizosa DR, Soliman HH, Lila T, Reiss DJ, Pierce DW, Bhore R, Banerjee S, Lyons L, Louis CU, Ong TJ, O'Dwyer PJ) Clin Cancer Res 2020 Sep 15;26(18):4814-4822 73 Citations |
1 | Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma. (Kandimalla R, Shimura T, Mallik S, Sonohara F, Tsai S, Evans DB, Kim SC, Baba H, Kodera Y, Von Hoff D, Chen X, Goel A) Ann Surg 2022 Jan 01;275(1):e229-e237 14 Citations |
3 | Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. (Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC) J Surg Oncol 2020 Aug;122(2):176-182 8 Citations |
1 | Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. (Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi B) J Surg Oncol 2020 Sep;122(3):495-505 9 Citations |
2 | Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma. (Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE) Ann Diagn Pathol 2020 Jun;46:151485 5 Citations |
1 | Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. (Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A, Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian VG) Hepatology 2020 Dec;72(6):2014-2028 66 Citations |
1 | Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma. (Reid JH, Marini BL, Nachar VR, Brown AM, Devata S, Perissinotti AJ) Crit Rev Oncol Hematol 2020 Apr;148:102897 3 Citations |
3 | Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis. (Shah NN, Ahn KW, Litovich C, Sureda A, Kharfan-Dabaja MA, Awan FT, Ganguly S, Gergis U, Inwards D, Karmali R, Lazaryan A, Lekakis L, Munshi P, Nathan S, Saad AA, Solh M, Steinberg A, Vij R, Wood WA, Fenske TS, Smith S, Hamadani M) Blood Cancer J 2019 Dec 03;9(12):97 11 Citations |
2 | White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. (Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, Hecht EM, Kastrinos F, Wang ZJ, Soloff EV, Tolat PP, Sangster G, Fleming J, Tamm EP, Kambadakone AR) Abdom Radiol (NY) 2020 Mar;45(3):729-742 22 Citations |
2 | White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. (Kulkarni NM, Soloff EV, Tolat PP, Sangster GP, Fleming JB, Brook OR, Wang ZJ, Hecht EM, Zins M, Bhosale PR, Arif-Tiwari H, Mannelli L, Kambadakone AR, Tamm EP) Abdom Radiol (NY) 2020 Mar;45(3):716-728 35 Citations |
2 | Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation. (Herr MM, Curtis RE, Tucker MA, Tecca HR, Engels EA, Cahoon EK, Battiwalla M, Buchbinder D, Flowers ME, Brazauskas R, Shaw BE, Morton LM) J Am Acad Dermatol 2020 Sep;83(3):762-772 8 Citations |
1 | Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages. (Behring M, Vazquez AI, Cui X, Irvin MR, Ojesina AI, Agarwal S, Manne U, Shrestha S) Mol Genet Genomic Med 2019 Dec;7(12):e1001 8 Citations |
1 | Stereotactic body radiation therapy and immunotherapy. (Khalife M, Shahid K, Dabney RS, Phan AT) Clin Adv Hematol Oncol 2019 Sep;17(9):518-523 3 Citations |
1 | Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. (Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM) Radiother Oncol 2019 Dec;141:137-143 9 Citations |
1 | Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients. (Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B) Ann Thorac Surg 2020 Feb;109(2):404-411 7 Citations |
7 | Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. (North L, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Graboyes E, Pipkorn P, Zenga J) Am J Otolaryngol 2019;40(6):102282 10 Citations |
1 | Initial Experience With Staging Rectal Adenocarcinoma Using 7T Magnetic Resonance Imaging. (Blank J, Berger N, Knechtges P, Prost R, Peterson C, Ludwig K, Ridolfi T) J Surg Res 2020 Jan;245:434-440 1 Citation |
6 | The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence. (Neuner JM, Fergestrom NM, Laud PW, Nattinger AB, Beyer KMM, Flynn KE, Pezzin LE) Cancer 2019 Nov 15;125(22):3960-3965 5 Citations |
1 | Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer. (Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB) Ann Surg 2019 Sep;270(3):400-413 116 Citations |
2 | Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma. (Doolittle J, Piotrowski J, Zuk K, Jacobsohn K, Langenstroer P, See W, Johnson S) Urology 2019 Oct;132:136-142 25 Citations |
7 | Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK) Surgery 2019 Sep;166(3):277-285 40 Citations |
1 | Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. (Chouliaras K, Senehi R, Ethun CG, Poultsides G, Tran T, Grignol V, Gamblin TC, Roggin KK, Tseng J, Fields RC, Weber SM, Russell GB, Levine EA, Cardona K, Votanopoulos K) J Surg Oncol 2019 Sep;120(3):340-347 25 Citations |
6 | Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer. (Zenga J, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Wong S, Jackson RS, Pipkorn P) Laryngoscope 2020 Mar;130(3):666-671 11 Citations |
3 | The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. (Gannon NP, King DM, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Votanopoulos K, Krasnick B, Fields RC, Cardona K, Bedi M) J Surg Oncol 2019 Sep;120(3):325-331 15 Citations |
4 | Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome. (Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ) Breast Cancer Res Treat 2019 Aug;177(1):77-91 3 Citations |
1 | Comprehensive genomic profiling of high-grade serous ovarian carcinoma from Chinese patients identifies co-occurring mutations in the Ras/Raf pathway with TP53. (Zhong F, Zhu T, Pan X, Zhang Y, Yang H, Wang X, Hu J, Han H, Mei L, Chen D, Wang K, Zhou X, Li X, Dong X) Cancer Med 2019 Jul;8(8):3928-3935 6 Citations |
1 | A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. (Luo CL, Rong Y, Chen H, Zhang WW, Wu L, Wei D, Wei XQ, Mei LJ, Wang FB) Technol Cancer Res Treat 2019 Jan 01;18:1533033819846632 16 Citations |
4 | Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study. (Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong JC) J Surg Res 2019 Oct;242:23-30 22 Citations |
1 | Predictors of swallow function after transoral surgery for locally advanced oropharyngeal cancer. (Gross JH, Townsend M, Hong HY, Miller E, Kallogjeri D, Zenga J, Pipkorn P, Jackson RS, Haughey B, Rich JT) Laryngoscope 2020 Jan;130(1):94-100 7 Citations |
1 | Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. (Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M 3rd, Zeitzer KL, Firat SY, Husain SM, D'Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM) Int J Radiat Oncol Biol Phys 2019 Aug 01;104(5):1057-1065 8 Citations |
1 | Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. (Zenga J, Yu Z, Parikh A, Chen JX, Lin DT, Emerick KS, Faquin WC, Varvares MA, Deschler DG) ORL J Otorhinolaryngol Relat Spec 2019;81(1):55-62 16 Citations |
2 | Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial. (Sun A, Hu C, Wong SJ, Gore E, Videtic G, Dutta S, Suntharalingam M, Chen Y, Gaspar LE, Choy H) JAMA Oncol 2019 Jun 01;5(6):847-855 49 Citations |
1 | Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors. (Senguttuvan Karthikeyan V, Mallya A, Sivaraman A, Galiano M, Rozet F, Cathala N, Barret E, Mombet A, Prapotnich D, Sanchez-Salas R, Cathelineau X) Actas Urol Esp (Engl Ed) 2019 Jun;43(5):234-240 1 Citation |
2 | Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma. (Gannon NP, Stemm MH, King DM, Bedi M) J Cancer Res Clin Oncol 2019 May;145(5):1321-1330 19 Citations |
1 | Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. (Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N) Gastroenterology 2019 Jun;156(8):2242-2253.e4 209 Citations |
1 | Management of Nodal Disease in Advanced Cervical Cancer. (Jürgenliemk-Schulz IM, Beriwal S, de Leeuw AAC, Lindegaard JC, Nomden CN, Pötter R, Tanderup K, Viswanathan AN, Erickson B) Semin Radiat Oncol 2019 Apr;29(2):158-165 30 Citations |
1 | GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study. (Brooks RA, Tritchler DS, Darcy KM, Lankes HA, Salani R, Sperduto P, Guntupalli S, DiSilvestro P, Kesterson J, Olawaiye AB, Moxley K, Waggoner S, Santin A, Rader JS, Kizer NT, Thaker PH, Powell MA, Mutch DG, Birrer MJ, Goodfellow PJ) Gynecol Oncol 2019 May;153(2):335-342 5 Citations |
3 | Does Vacuum-assisted Closure Reduce the Risk of Wound Complications in Patients With Lower Extremity Sarcomas Treated With Preoperative Radiation? (Bedi M, King DM, DeVries J, Hackbarth DA, Neilson JC) Clin Orthop Relat Res 2019 Apr;477(4):768-774 24 Citations |
6 | Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study. (Zenga J, Graboyes E, Janz T, Drake V, Rettig E, Desai S, Nickel C, Shabani S, Padhya T, Scarpinato M, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Wong S, Jackson RS, Pipkorn P) Otolaryngol Head Neck Surg 2019 Jul;161(1):74-81 14 Citations |
1 | Rapid Research Autopsy: Piecing the Puzzle of Tumor Heterogeneity. (Krook MA, Chen HZ, Bonneville R, Allenby P, Roychowdhury S) Trends Cancer 2019 Jan;5(1):1-5 10 Citations |
1 | Kinetic modeling of tumor regression incorporating the concept of cancer stem-like cells for patients with locally advanced lung cancer. (Zhong H, Brown S, Devpura S, Li XA, Chetty IJ) Theor Biol Med Model 2018 Dec 27;15(1):23 4 Citations |
4 | Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen. (Shah NN, Szabo A, Saba R, Strelec L, Kodali D, Vaughn JL, Esan O, Yang DT, Mato AR, Kanate AS, Olteanu H, Hamadani M, Fenske TS, Kenkre VP, Svoboda J, Cashen AF, Epperla N) Clin Lymphoma Myeloma Leuk 2019 Feb;19(2):95-102 9 Citations |
4 | Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma. (Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RP, Kamble R, Diaz MA, Lazarus HM, Savani BN, Hildebrandt GC, Solh M, Freytes CO, Lee C, Kyle RA, Usmani SZ, Ganguly S, Assal A, Berdeja J, Kanate AS, Dhakal B, Meehan K, Kindwall-Keller T, Saad A, Locke F, Seo S, Nishihori T, Gergis U, Gasparetto C, Mark T, Nieto Y, Kumar S, Hari P) Biol Blood Marrow Transplant 2019 Apr;25(4):683-688 17 Citations |
2 | Rete Testis Invasion Is Consistent With Pathologic Stage T1 in Germ Cell Tumors. (Farooq A, Jorda M, Whittington E, Kryvenko ON, Braunhut BL, Pavan N, Procházková K, Zhang L, Rai S, Miller T, Liu J, Szabo A, Iczkowski KA) Am J Clin Pathol 2019 Apr 02;151(5):479-485 4 Citations |
1 | Improved long-term patient-reported health and well-being outcomes of early-stage breast cancer treated with partial breast proton therapy. (Teichman SL, Do S, Lum S, Teichman TS, Preston W, Cochran SE, Garberoglio CA, Grove R, Davis CA, Slater JD, Bush DA) Cancer Med 2018 Dec;7(12):6064-6076 11 Citations |
1 | Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios. (Gallan AJ, Choy B, Paner GP) Surg Pathol Clin 2018 Dec;11(4):775-795 7 Citations |
1 | E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma. (Tarhini AA, Lee SJ, Li X, Rao UNM, Nagarajan A, Albertini MR, Mitchell JW Jr, Wong SJ, Taylor MA, Laudi N, Truong PV, Conry RM, Kirkwood JM) Clin Cancer Res 2019 Jan 15;25(2):524-532 8 Citations |
1 | Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma. (Kato S, Okamura R, Baumgartner JM, Patel H, Leichman L, Kelly K, Sicklick JK, Fanta PT, Lippman SM, Kurzrock R) Clin Cancer Res 2018 Dec 15;24(24):6248-6256 77 Citations |
1 | Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. (Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, Lesoin A, Schwartz PE, Buscema J, Fabbro M, Lortholary A, Goff B, Kurzrock R, Martin LP, Gray HJ, Fu S, Sheldon-Waniga E, Lin HM, Venkatakrishnan K, Zhou X, Leonard EJ, Schilder RJ) JAMA Oncol 2019 Jan 01;5(1):e183773 56 Citations |
1 | Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 Nov;19(11):1504-1515 157 Citations |
5 | Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2020 Apr;271(4):740-747 119 Citations |
2 | Novel biomarkers in multiple myeloma. (Levin A, Hari P, Dhakal B) Transl Res 2018 Nov;201:49-59 32 Citations |
1 | Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma. (Maffini E, Storer BE, Sandmaier BM, Bruno B, Sahebi F, Shizuru JA, Chauncey TR, Hari P, Lange T, Pulsipher MA, McSweeney PA, Holmberg L, Becker PS, Green DJ, Mielcarek M, Maloney DG, Storb R) Haematologica 2019 Feb;104(2):380-391 21 Citations |
2 | A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database. (Johnson AC, Ethun CG, Liu Y, Poultsides G, Howard JH, Bedi M, Charlson J, Tseng J, Roggin KK, Votanopoulos K, Cullinan D, Fields RC, Maithel SK, Cardona K, and other members of the US Sarcoma Collaborative) J Surg Oncol 2018 Dec;118(7):1135-1141 6 Citations |
1 | What Makes a Pancreatic Cancer Resectable? (Evans DB) Am Soc Clin Oncol Educ Book 2018 May 23;38:300-305 |
1 | Evaluation, Staging, and Surgical Management for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group. (Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, Solórzano CC) Ann Surg Oncol 2018 Nov;25(12):3460-3468 22 Citations |
1 | Obesity and mortality after locoregional breast cancer diagnosis. (Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness DJ, Hampton J, Wu XC, Anderson RT, Lipscomb J, Kimmick GG, Cress R, Wilson JF, Sabatino SA, Fleming ST) Breast Cancer Res Treat 2018 Dec;172(3):647-657 6 Citations |
3 | Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups. (Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A) Biol Blood Marrow Transplant 2018 Dec;24(12):2443-2449 12 Citations |
1 | Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. (Wang TS, Sosa JA) Nat Rev Endocrinol 2018 Nov;14(11):670-683 152 Citations |
1 | Imaging predictors of treatment outcomes in rectal cancer: An overview. (Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA) Crit Rev Oncol Hematol 2018 Sep;129:153-162 16 Citations |
1 | Are Providers and Patients Following Hormonal Therapy Guidelines for Patients Over the Age of 70? The Influence of CALGB 9343. (Cortina CS, Agarwal S, Mulder LL, Poirier J, Rao R, Ansell DA, Madrigrano A) Clin Breast Cancer 2018 Dec;18(6):e1289-e1292 9 Citations |
1 | Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031. (McCarten KM, Metzger ML, Drachtman RA, Pei Q, Friedman DL, Schwartz CL, Kelly KM) Pediatr Radiol 2018 Nov;48(12):1736-1744 14 Citations |
1 | Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. (Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A) Cancer 2018 Sep 01;124(17):3510-3519 56 Citations |
1 | Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. (Zenga J, Parikh AS, Emerick KS, Lin DT, Faquin WC, Deschler DG) JAMA Otolaryngol Head Neck Surg 2018 Nov 01;144(11):1011-1016 32 Citations |
2 | Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. (McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS) Int J Radiat Oncol Biol Phys 2018 Aug 01;101(5):1179-1187 40 Citations |
1 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. (Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, Zou W, Montgomery B, Alva A, PCF/SU2C International Prostate Cancer Dream Team, Robinson DR, Chinnaiyan AM) Cell 2018 Jun 14;173(7):1770-1782.e14 372 Citations |
1 | Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes. (Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD) J Vasc Interv Radiol 2018 Aug;29(8):1122-1126 12 Citations |
3 | The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer. (Kong AL, Nattinger AB, McGinley E, Pezzin LE) Breast Cancer Res Treat 2018 Sep;171(2):477-488 6 Citations |
1 | Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer. (Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, Choy H) JAMA Oncol 2018 Sep 01;4(9):1287-1288 160 Citations |
1 | Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. (Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H) JAMA Oncol 2018 Sep 01;4(9):1263-1266 240 Citations |
2 | Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group). (Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, Eun D, Perdona S, Porter J, Rha KH, Mottrie A, White WM, Schips L, Yang B, Jacobsohn K, Uzzo RG, Challacombe B, Ferro M, Sulek J, Capitanio U, Anele UA, Tuderti G, Costantini M, Ryan S, Bindayi A, Mari A, Carini M, Keehn A, Quarto G, Liao M, Chang K, Larcher A, De Naeyer G, De Cobelli O, Berardinelli F, Zhang C, Langenstroer P, Kutikov A, Chen D, De Luyk N, Sundaram CP, Montorsi F, Stein RJ, Haber GP, Hampton LJ, Dasgupta P, Gallucci M, Kaouk J, Porpiglia F) Eur Urol 2018 Aug;74(2):226-232 99 Citations |
1 | Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases. (Dwyer RH, Scheidt MJ, Marshall JS, Tsoraides SS) J Robot Surg 2018 Dec;12(4):603-606 30 Citations |
6 | Postoperative Day 1 Glucose May Be Associated With Wound Complications in Sarcomas Treated With Preoperative Radiation. (Bedi M, King DM, Mendez C, Slawski B, Charlson JA, Hackbarth DA, Neilson JC) Clin Orthop Relat Res 2018 Mar;476(3):580-586 1 Citation |
1 | Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer? (Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J) Investig Clin Urol 2018 Mar;59(2):83-90 6 Citations |
1 | STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. (Maranto C, Udhane V, Hoang DT, Gu L, Alexeev V, Malas K, Cardenas K, Brody JR, Rodeck U, Bergom C, Iczkowski KA, Jacobsohn K, See W, Schmitt SM, Nevalainen MT) Clin Cancer Res 2018 Apr 15;24(8):1917-1931 42 Citations |
1 | A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. (Rudolph M, Sizemore ST, Lu Y, Teng KY, Basree MM, Reinbolt R, Timmers CD, Leone G, Ostrowski MC, Majumder S, Ramaswamy B) Breast Cancer Res Treat 2018 Jun;169(3):457-467 8 Citations |
1 | Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus. (Schrock AB, Pavlick D, Klempner SJ, Chung JH, Forcier B, Welsh A, Young L, Leyland-Jones B, Bordoni R, Carvajal RD, Chao J, Kurzrock R, Sicklick JK, Ross JS, Stephens PJ, Devoe C, Braiteh F, Ali SM, Miller VA) Clin Cancer Res 2018 Apr 15;24(8):1881-1890 51 Citations |
5 | Locally advanced pancreas cancer: Staging and goals of therapy. (Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK) Surgery 2018 May;163(5):1053-1062 45 Citations |
4 | R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis. (Shah NN, Szabo A, Huntington SF, Epperla N, Reddy N, Ganguly S, Vose J, Obiozor C, Faruqi F, Kovach AE, Costa LJ, Xavier AC, Okal R, Kanate AS, Ghosh N, Kharfan-Dabaja MA, Strelec L, Hamadani M, Fenske TS, Calzada O, Cohen JB, Chavez J, Svoboda J) Br J Haematol 2018 Feb;180(4):534-544 69 Citations |
1 | Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment. (Qu LT, Peters S, Cobb AN, Godellas CV, Perez CB, Vaince FT) Am J Surg 2018 Mar;215(3):530-533 6 Citations |
5 | Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. (Bhalla M, Aldakkak M, Kulkarni NM, O'Connor SD, Griffin MO Jr, Christians KK, Evans DB, Tsai S, Tolat PP) Abdom Radiol (NY) 2018 Feb;43(2):351-363 11 Citations |
1 | Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer. (Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu XC, Written on behalf of the Center for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group) J Geriatr Oncol 2018 May;9(3):214-220 23 Citations |
1 | A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. (Poorman CE, Ethun CG, Postlewait LM, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solórzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK) Ann Surg Oncol 2018 Feb;25(2):520-527 15 Citations |
1 | Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. (Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A) J Natl Cancer Inst 2018 May 01;110(5):460-466 16 Citations |
1 | The diagnostic value and histologic correlate of distinct patterns of shiny white streaks for the diagnosis of melanoma: A retrospective, case-control study. (Verzi AE, Quan VL, Walton KE, Martini MC, Marghoob AA, Garfield EM, Kong BY, Isales MC, VandenBoom T, Zhang B, West DP, Gerami P) J Am Acad Dermatol 2018 May;78(5):913-919 18 Citations |
1 | Pancreatic adenocarcinoma: cross-sectional imaging techniques. (Kulkarni NM, Hough DM, Tolat PP, Soloff EV, Kambadakone AR) Abdom Radiol (NY) 2018 Feb;43(2):253-263 16 Citations |
1 | The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. (Koay EJ, Hall W, Park PC, Erickson B, Herman JM) Abdom Radiol (NY) 2018 Feb;43(2):393-403 5 Citations |
1 | Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. (Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM) Cancer 2018 Jan 01;124(1):136-144 45 Citations |
1 | Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes. (Garcia-Barreras S, Sanchez-Salas R, Sivaraman A, Barret E, Secin F, Nunes-Silva I, Linares-Espinós E, Rozet F, Galiano M, Cathelineau X) J Urol 2018 Jan;199(1):140-146 27 Citations |
5 | Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. (Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD) Cancer 2017 Dec 01;123(23):4687-4700 45 Citations |
1 | Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease. (Cohen PR, Kato S, Goodman AM, Ikeda S, Kurzrock R) Int J Mol Sci 2017 Jul 31;18(8) 30 Citations |
1 | Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice. (Patten CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, Forster MR, Robinson M, White RL Jr) J Surg Oncol 2017 Dec;116(8):1040-1045 20 Citations |
4 | Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features. (Hopp EE, Cossette SM, Kumar SN, Eastwood D, Ramchandran R, Bishop E) Cancer Invest 2017 Aug 09;35(7):456-462 4 Citations |
1 | Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3? (Gordetsky J, Sanfrancesco J, Epstein JI, Trevino K, Xu H, Osunkoya A, Xiao GQ, Kao CS, Unger P, Hashemi-Sadraei N, Albany C, Jorns JM, Lu DY, Matoso A, Rais-Bahrami S, Schwartz LE, Ulbright TM, Idrees MT) Am J Surg Pathol 2017 Oct;41(10):1397-1402 11 Citations |
1 | Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. (Buettner S, Galjart B, van Vugt JLA, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Groot Koerkamp B, Pawlik TM) J Surg Oncol 2017 Dec;116(8):1085-1095 38 Citations |
1 | Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. (Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD) J Thorac Oncol 2017 Sep;12(9):1413-1420 18 Citations |
3 | Efficacy of a Weight Loss Intervention for African American Breast Cancer Survivors. (Stolley M, Sheean P, Gerber B, Arroyo C, Schiffer L, Banerjee A, Visotcky A, Fantuzzi G, Strahan D, Matthews L, Dakers R, Carridine-Andrews C, Seligman K, Springfield S, Odoms-Young A, Hong S, Hoskins K, Kaklamani V, Sharp L) J Clin Oncol 2017 Aug 20;35(24):2820-2828 36 Citations |
1 | Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. (Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA) Surgery 2017 Sep;162(3):500-514 52 Citations |
1 | Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma. (Schwaederlé MC, Patel SP, Husain H, Ikeda M, Lanman RB, Banks KC, Talasaz A, Bazhenova L, Kurzrock R) Clin Cancer Res 2017 Sep 01;23(17):5101-5111 112 Citations |
1 | Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. (Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J) Cancer 2017 Sep 15;123(18):3486-3493 87 Citations |
3 | Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report. (Schriber JR, Hari PN, Ahn KW, Fei M, Costa LJ, Kharfan-Dabaja MA, Angel-Diaz M, Gale RP, Ganguly S, Girnius SK, Hashmi S, Pawarode A, Vesole DH, Wiernik PH, Wirk BM, Marks DI, Nishihori T, Olsson RF, Usmani SZ, Mark TM, Nieto YL, D'Souza A) Cancer 2017 Aug 15;123(16):3141-3149 66 Citations |
1 | Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2. (Bishop EA, Java JJ, Moore KN, Walker JL) Int J Gynecol Cancer 2017 May;27(4):730-737 14 Citations |
1 | Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease. (Harrison DJ, Schwartz CL) Curr Treat Options Oncol 2017 Apr;18(4):24 48 Citations |
1 | The Significance of Lymphovascular Invasion of the Spermatic Cord in the Absence of Cord Soft Tissue Invasion. (McCleskey BC, Epstein JI, Albany C, Hashemi-Sadraei N, Idrees MT, Jorns JM, Lu DY, Matoso A, Rais-Bahrami S, Schwartz LE, Ulbright TM, Gordetsky J) Arch Pathol Lab Med 2017 Jun;141(6):824-829 13 Citations |
1 | Treatment outcomes in veterans with HPV-positive head and neck cancer. (Feinstein AJ, Shay SG, Chang E, Lewis MS, Wang MB) Am J Otolaryngol 2017;38(2):188-192 13 Citations |
1 | Fine mapping of chromosome 5p15.33 identifies novel lung cancer susceptibility loci in Han Chinese. (Dong J, Cheng Y, Zhu M, Wen Y, Wang C, Wang Y, Geng L, Shen W, Liu J, Li Z, Zhang J, Ma H, Dai J, Jin G, Hu Z, Shen H) Int J Cancer 2017 Aug 01;141(3):447-456 13 Citations |
3 | An Evidence-based Recommendation for a Standardized Approach to Detecting Metastatic Neuroblastoma in Staging Bone Marrow Biopsies. (Parsons LN, Gheorghe G, Yan K, Simpson P, Jarzembowski JA) Pediatr Dev Pathol 2017;20(1):38-43 3 Citations |
1 | Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. (Gould JC, Wendling MR, Oeschlager BK, Mittal SK, Komanduri S, Perry KA, Cleary S, Galandiuk S, Scott DJ, Fisichella PM, Shaheen NJ, Haisley KR, Hunter JG) J Gastrointest Surg 2017 Aug;21(8):1342-1349 4 Citations |
1 | Accuracy and Thoroughness of Treatment Summaries Provided as Part of Survivorship Care Plans Prepared by Two Cancer Centers. (Tevaarwerk AJ, Hocking WG, Zeal JL, Gribble M, Seaborne L, Buhr KA, Wisinski KB, Burkard ME, Wiegmann DA, Sesto ME) J Oncol Pract 2017 May;13(5):e486-e495 13 Citations |
1 | The Hybrid Transoral-Pharyngotomy Approach to Oropharyngeal Carcinoma: Technique and Outcome. (Sinha P, Pipkorn P, Zenga J, Haughey BH) Ann Otol Rhinol Laryngol 2017 May;126(5):357-364 5 Citations |
2 | Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis. (Ustun C, Giannotti F, Zhang MJ, Wang HL, Brunstein C, Labopin M, Rocha V, de Lima M, Baron F, Sandmaier BM, Eapen M, Gluckman E, Nagler A, Weisdorf DJ, Ruggeri A) Leukemia 2017 Jun;31(6):1408-1414 19 Citations |
1 | hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells. (Karmakar S, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Sheinin YM, Mahapatra S, Batra SK, Ponnusamy MP) Oncotarget 2017 Feb 28;8(9):14806-14820 25 Citations |
3 | Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. (Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA) Pract Radiat Oncol 2017;7(2):126-136 39 Citations |
2 | Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database. (Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston FM) Ann Palliat Med 2017 Jan;6(1):26-35 12 Citations |
1 | Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. (Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN) Ann Surg 2018 Mar;267(3):514-520 56 Citations |
1 | Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. (Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M) Neuro Oncol 2017 Feb 01;19(2):252-258 58 Citations |
1 | Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample. (Griggs JJ, Hamilton AS, Schwartz KL, Zhao W, Abrahamse PH, Thomas DG, Jorns JM, Jewell R, Saber ME, Haque R, Katz SJ) Breast Cancer Res Treat 2017 Jan;161(2):375-384 20 Citations |
1 | Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. (Liu F, Tai A, Lee P, Biswas T, Ding GX, El Naqa I, Grimm J, Jackson A, Kong FS, LaCouture T, Loo B Jr, Miften M, Solberg T, Li XA) Radiother Oncol 2017 Feb;122(2):286-294 43 Citations |
5 | Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study. (Yen TW, Pezzin LE, Li J, Sparapani R, Laud PW, Nattinger AB) Cancer 2017 May 15;123(6):957-966 29 Citations |
4 | Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease. (Tsai S, Christians KK, Ritch PS, George B, Khan AH, Erickson B, Evans DB) J Oncol Pract 2016 Oct;12(10):915-923 18 Citations |
1 | Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decade. (Packiam VT, Agrawal VA, Cohen AJ, Pariser JJ, Johnson SC, Bales GT, Smith ND, Steinberg GD) Urol Oncol 2017 Mar;35(3):112.e19-112.e25 15 Citations |
1 | Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors. (Wang J, Ye Z, Huang TH, Shi H, Jin VX) Methods Mol Biol 2017;1513:163-170 10 Citations |
1 | Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group. (Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, de Alarcon PA, Keller FG, Kelly KM, Trippet TA, Voss SD, Friedman DL) Pediatr Blood Cancer 2017 Apr;64(4) 42 Citations |
5 | Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated? (Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB, Tsai S) J Surg Oncol 2016 Oct;114(5):581-586 21 Citations |
3 | Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation. (Epperla N, Shah N, Hamadani M, Richardson K, Kapke JT, Patel A, Teegavarapu SP, Carrum G, Hari PN, Pingali SR, Karmali R, Fenske TS) Clin Lymphoma Myeloma Leuk 2016 Dec;16(12):672-678 7 Citations |
1 | Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. (Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christian KK, Johnston FM, Pawlik TM, Gamblin TC) Ann Surg Oncol 2016 Dec;23(Suppl 5):912-920 25 Citations |
3 | Evolution of the Management of Resectable Pancreatic Cancer. (Tsai S, Erickson BA, Dua K, Ritch PS, Tolat P, Evans DB) J Oncol Pract 2016 Sep;12(9):772-8 23 Citations |
1 | Management Controversies in Head and Neck Melanoma: A Systematic Review. (Zenga J, Nussenbaum B, Cornelius LA, Linette GP, Desai SC) JAMA Facial Plast Surg 2017 Jan 01;19(1):53-62 18 Citations |
1 | Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. (Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, Stock R, Stone NN, Sydes MR, Tyrer JP, Ahmed S, Parliament M, Ostrer H, Rosenstein BS, Vega A, Burnet NG, Dunning AM, Barnett GC, West CM, Radiogenomics Consortium) EBioMedicine 2016 Aug;10:150-63 64 Citations |
7 | Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer. (Bergom C, Kelly T, Bedi M, Saeed H, Prior P, Rein LE, Szabo A, Wilson JF, Currey AD, White J) Int J Radiat Oncol Biol Phys 2016 Sep 01;96(1):65-71 21 Citations |
1 | Genomic Landscape of Malignant Mesotheliomas. (Kato S, Tomson BN, Buys TP, Elkin SK, Carter JL, Kurzrock R) Mol Cancer Ther 2016 Oct;15(10):2498-2507 59 Citations |
1 | Ultrasound-Guided Placement of Gold Fiducial Markers for Stereotactic Partial-Breast Irradiation. (Seiler S, Rahimi A, Choudhery S, Garwood D, Spangler A, Cherian S, Goudreau S) AJR Am J Roentgenol 2016 Sep;207(3):685-8 14 Citations |
4 | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer. (Yen TWF, Li J, Sparapani RA, Laud PW, Nattinger AB) Medicine (Baltimore) 2016 Aug;95(31):e4392 18 Citations |
1 | Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer. (White J, Winter K, Kuske RR, Bolton JS, Arthur DW, Scroggins T, Rabinovitch RA, Kelly T, Toonkel LM, Vicini FA, McCormick B) Int J Radiat Oncol Biol Phys 2016 Aug 01;95(5):1460-1465 45 Citations |
1 | Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B). (Bell R, Pandanaboyana S, Lodge JPA, Prasad KR, Jones R, Hidalgo E) Langenbecks Arch Surg 2017 Jun;402(4):575-583 8 Citations |
1 | Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer. (Teagle AR, Gilbert DC, Jones JR, Burkill GJ, McKinna F, Dizdarevic S) Nucl Med Commun 2016 Oct;37(10):1038-45 14 Citations |
1 | Colon cancer operations at high- and low-mortality hospitals. (Healy MA, Grenda TR, Suwanabol PA, Yin H, Ghaferi AA, Birkmeyer JD, Wong SL) Surgery 2016 Aug;160(2):359-65 5 Citations |
3 | Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis. (Deol A, Sengsayadeth S, Ahn KW, Wang HL, Aljurf M, Antin JH, Battiwalla M, Bornhauser M, Cahn JY, Camitta B, Chen YB, Cutler CS, Gale RP, Ganguly S, Hamadani M, Inamoto Y, Jagasia M, Kamble R, Koreth J, Lazarus HM, Liesveld J, Litzow MR, Marks DI, Nishihori T, Olsson RF, Reshef R, Rowe JM, Saad AA, Sabloff M, Schouten HC, Shea TC, Soiffer RJ, Uy GL, Waller EK, Wiernik PH, Wirk B, Woolfrey AE, Bunjes D, Devine S, de Lima M, Sandmaier BM, Weisdorf D, Khoury HJ, Saber W) Cancer 2016 Oct;122(19):3005-3014 39 Citations |
1 | Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study. (Wheler JJ, Janku F, Naing A, Li Y, Stephen B, Zinner R, Subbiah V, Fu S, Karp D, Falchook GS, Tsimberidou AM, Piha-Paul S, Anderson R, Ke D, Miller V, Yelensky R, Lee JJ, Hong DS, Kurzrock R) Cancer Res 2016 Jul 01;76(13):3690-701 184 Citations |
1 | Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. (Guancial EA, Kilari D, Xiao GQ, Abu-Farsakh SH, Baran A, Messing EM, Kim ES) PLoS One 2016;11(5):e0155503 6 Citations |
10 | Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. (Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN) Clin Lymphoma Myeloma Leuk 2016 Jul;16(7):379-86 15 Citations |
1 | Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain. (Divine LM, Kizer NT, Hagemann AR, Pittman ME, Chen L, Powell MA, Mutch DG, Rader JS, Thaker PH) Gynecol Oncol 2016 Jul;142(1):76-82 24 Citations |
1 | Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents. (Devata S, Wilcox RA) Am J Clin Dermatol 2016 Jun;17(3):225-37 26 Citations |
1 | Evaluation of a post-treatment follow-up program in patients with oral squamous cell carcinoma. (Peisker A, Raschke GF, Guentsch A, Luepke P, Roshanghias K, Schultze-Mosgau S) Clin Oral Investig 2017 Jan;21(1):135-141 5 Citations |
1 | Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer. (Zenga J, Graboyes EM, Haughey BH, Paniello RC, Mehrad M, Lewis JS Jr, Thorstad WL, Nussenbaum B, Rich JT) Otolaryngol Head Neck Surg 2016 Apr;154(4):657-66 15 Citations |
1 | Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients. (Kilari D, Iczkowski KA, Pandya C, Robin AJ, Messing EM, Guancial E, Kim ES) Anticancer Res 2016 Feb;36(2):495-501 43 Citations |
3 | Management of suspected adrenal metastases at 2 academic medical centers. (Glenn JA, Kiernan CM, Yen TW, Solorzano CC, Carr AA, Evans DB, Wang TS) Am J Surg 2016 Apr;211(4):664-70 20 Citations |
1 | De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. (Alinari L, Gru A, Quinion C, Huang Y, Lozanski A, Lozanski G, Poston J, Venkataraman G, Oak E, Kreisel F, Park SI, Matthews S, Abramson JS, Iris Lim H, Martin P, Cohen JB, Evens A, Al-Mansour Z, Singavi A, Fenske TS, Blum KA) Am J Hematol 2016 Jun;91(4):395-9 48 Citations |
1 | Outcomes with multimodal therapy for elderly patients with rectal cancer. (Thiels CA, Bergquist JR, Meyers AJ, Johnson CL, Behm KT, Hayman AV, Habermann EB, Larson DW, Mathis KL) Br J Surg 2016 Jan;103(2):e106-14 19 Citations |
1 | FOXM1 is a therapeutic target for high-risk multiple myeloma. (Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, Janz S) Leukemia 2016 Apr;30(4):873-82 39 Citations |
1 | Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. (Yu W, Denu RA, Krautkramer KA, Grindle KM, Yang DT, Asimakopoulos F, Hematti P, Denu JM) J Biol Chem 2016 Feb 12;291(7):3268-79 70 Citations |
1 | Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer. (Branham MT, Campoy E, Laurito S, Branham R, Urrutia G, Orozco J, Gago F, Urrutia R, Roqué M) Breast Cancer Res Treat 2016 Jan;155(1):13-23 12 Citations |
5 | Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S) Surgery 2016 Mar;159(3):893-900 102 Citations |
1 | First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies. (Munster P, Aggarwal R, Hong D, Schellens JH, van der Noll R, Specht J, Witteveen PO, Werner TL, Dees EC, Bergsland E, Agarwal N, Kleha JF, Durante M, Adams L, Smith DA, Lampkin TA, Morris SR, Kurzrock R) Clin Cancer Res 2016 Apr 15;22(8):1932-9 73 Citations |
5 | Reexamining the Relationship of Breast Cancer Hospital and Surgical Volume to Mortality: An Instrumental Variable Analysis. (Pezzin LE, Laud P, Yen TW, Neuner J, Nattinger AB) Med Care 2015 Dec;53(12):1033-9 28 Citations |
4 | Improving Detection of Metastatic Neuroblastoma in Bone Marrow Core Biopsies: A Proposed Immunohistochemical Approach. (Parsons LN, Gheorghe G, Yan K, Simpson P, Jarzembowski JA) Pediatr Dev Pathol 2016;19(3):230-6 11 Citations |
1 | Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. (Bagante F, Gani F, Spolverato G, Xu L, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM) J Am Coll Surg 2015 Dec;221(6):1031-40.e1-4 64 Citations |
1 | High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. (Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ, Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh)) Ann Surg 2015 Dec;262(6):891-8 125 Citations |
2 | Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. (Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA) Conn Med 2015 Aug;79(7):401-4 |
1 | Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer. (Corcoran RB, Atreya CE, Falchook GS, Kwak EL, Ryan DP, Bendell JC, Hamid O, Messersmith WA, Daud A, Kurzrock R, Pierobon M, Sun P, Cunningham E, Little S, Orford K, Motwani M, Bai Y, Patel K, Venook AP, Kopetz S) J Clin Oncol 2015 Dec 01;33(34):4023-31 410 Citations |
2 | Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer. (Fang TC, Oh YS, Szabo A, Khan A, Dua KS) Dis Esophagus 2016 Aug;29(6):642-8 14 Citations |
2 | Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. (Margonis GA, Kim Y, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) Ann Surg Oncol 2016 Jan;23(1):134-41 67 Citations |
2 | Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence. (Amini N, Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) Ann Surg Oncol 2016 Jan;23(1):126-33 37 Citations |
4 | Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. (Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S) HPB (Oxford) 2015 Oct;17(10):942-52 50 Citations |
3 | Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. (Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK) Eur J Surg Oncol 2015 Oct;41(10):1386-92 66 Citations |
4 | Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. (Miura JT, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Oshima K, Christians KK, Evans DB, Tsai S) Surgery 2015 Dec;158(6):1545-55 28 Citations |
3 | Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis. (Miura JT, Johnston FM, Tsai S, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin TC) HPB (Oxford) 2015 Oct;17(10):896-901 34 Citations |
1 | Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. (Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan A) Brachytherapy 2015;14(5):587-99 74 Citations |
6 | Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. (Miura JT, Rilling WS, White SB, Hieb RA, Tutton SM, Patel PJ, Gamblin TC, Hohenwalter EJ) HPB (Oxford) 2015 Aug;17(8):707-12 12 Citations |
1 | Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma. (Hong DS, Kurzrock R, Wheler JJ, Naing A, Falchook GS, Fu S, Kim KB, Davies MA, Nguyen LM, George GC, Xu L, Shumaker R, Ren M, Mink J, Bedell C, Andresen C, Sachdev P, O'Brien JP, Nemunaitis J) Clin Cancer Res 2015 Nov 01;21(21):4801-10 60 Citations |
2 | Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy. (Evans DB, George B, Tsai S) Ann Surg Oncol 2015 Oct;22(11):3409-13 69 Citations |
1 | Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. (Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU) Int J Radiat Oncol Biol Phys 2015 Jul 15;92(4):863-73 27 Citations |
1 | Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. (Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, Rilling WS, Hong K, Putnam JB) Cancer 2015 Oct 01;121(19):3491-8 182 Citations |
1 | Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. (Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA) Am J Hematol 2015 Sep;90(9):778-83 71 Citations |
1 | Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes. (Kurzrock R, Giles FJ) Cell Cycle 2015;14(14):2219-21 57 Citations |
1 | Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types. (Schwaederle M, Elkin SK, Tomson BN, Carter JL, Kurzrock R) Cell Cycle 2015;14(14):2355-61 56 Citations |
1 | Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. (Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH) Lancet Oncol 2015 Jun;16(6):695-703 104 Citations |
1 | Analysis of free-form radiology dictations for completeness and clarity for pancreatic cancer staging. (Marcal LP, Fox PS, Evans DB, Fleming JB, Varadhachary GR, Katz MH, Tamm EP) Abdom Imaging 2015 Oct;40(7):2391-7 39 Citations |
1 | Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy. (Rodrigues HV, Ke D, Lim J, Stephen B, Bellido J, Janku F, Zinner R, Tsimberidou A, Hong D, Piha-Paul S, Fu S, Naing A, Subbiah V, Karp D, Falchook G, Kurzrock R, Wheler J) Invest New Drugs 2015 Jun;33(3):700-9 13 Citations |
1 | Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma. (Zenga J, Wilson M, Adkins DR, Gay HA, Haughey BH, Kallogjeri D, Michel LS, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B) JAMA Otolaryngol Head Neck Surg 2015 Dec;141(12):1118-27 30 Citations |
4 | Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. (Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS) J Neurooncol 2015 May;123(1):179-88 20 Citations |
1 | Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients. (Arva NC, Deitch SG) J Pediatr Endocrinol Metab 2015 Jul;28(7-8):753-60 7 Citations |
1 | Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer. (Moulder S, Helgason T, Janku F, Wheler J, Moroney J, Booser D, Albarracin C, Morrow PK, Atkins J, Koenig K, Gilcrease M, Kurzrock R) Ann Oncol 2015 Jul;26(7):1346-52 48 Citations |
5 | The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer. (Lai V, Yen TW, Rose BT, Fareau GG, Misustin SM, Evans DB, Wang TS) Ann Surg Oncol 2015 Dec;22(13):4181-6 7 Citations |
1 | Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. (Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z) Int J Cancer 2015 Oct 01;137(7):1679-90 177 Citations |
4 | Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. (Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T) Ann Surg Oncol 2015 Oct;22(11):3716-23 79 Citations |
2 | Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. (Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, Cooke KR) Leukemia 2015 Aug;29(8):1754-62 98 Citations |
1 | Clinicopathologic features and management of blastoid variant of mantle cell lymphoma. (Shrestha R, Bhatt VR, Guru Murthy GS, Armitage JO) Leuk Lymphoma 2015;56(10):2759-67 21 Citations |
1 | Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia. (Flynn J, Jones J, Johnson AJ, Andritsos L, Maddocks K, Jaglowski S, Hessler J, Grever MR, Im E, Zhou H, Zhu Y, Zhang D, Small K, Bannerji R, Byrd JC) Leukemia 2015 Jul;29(7):1524-9 91 Citations |
1 | A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. (Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, PRACTICAL Consortium, Australian Prostate Cancer BioResource, Spurdle AB, Clements JA, Park JY, Batra J) Cancer Discov 2015 Apr;5(4):368-79 51 Citations |
1 | Does initial laparoscopic cholecystectomy influence the outcomes of definitive oncologic resection for gallbladder cancer? (Ballo R, Saeed M, Daly S, Pinzon M, Francescatti A, Millikan KW, Myers JA, Bines SF, Luu MB) Am Surg 2015 Feb;81(2):E54-6 2 Citations |
1 | Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. (Chung TK, Van Hummelen P, Chan PK, Cheung TH, Yim SF, Yu MY, Ducar MD, Thorner AR, MacConaill LE, Doran G, Pedamallu CS, Ojesina AI, Wong RR, Wang VW, Freeman SS, Lau TS, Kwong J, Chan LK, Fromer M, May T, Worley MJ Jr, Esselen KM, Elias KM, Lawrence M, Getz G, Smith DI, Crum CP, Meyerson M, Berkowitz RS, Wong YF) Int J Cancer 2015 Aug 15;137(4):776-83 38 Citations |
1 | Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database. (Shukla ME, Yu C, Reddy CA, Stephans KL, Klein EA, Abdel-Wahab M, Ciezki J, Tendulkar RD) Clin Genitourin Cancer 2015 Feb;13(1):17-21 17 Citations |
1 | Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. (Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM) J Clin Oncol 2015 Feb 01;33(4):332-9 102 Citations |
1 | Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. (Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH) Ann Surg Oncol 2015 Jul;22(7):2416-23 121 Citations |
1 | Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience. (Sivaraman A, Sanchez-Salas R, Barret E, Macek P, Validire P, Galiano M, Rozet F, Cathelineau X) World J Urol 2015 Oct;33(10):1475-9 14 Citations |
2 | Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database. (Guru Murthy GS, Venkitachalam R, Mehta P) Clin Lymphoma Myeloma Leuk 2014 Sep;14 Suppl:S90-5 15 Citations |
2 | Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study. (Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Di Bacco A, Estevam J, Gupta N, Hui AM, Rajkumar V, Richardson PG) Lancet Oncol 2014 Dec;15(13):1503-1512 243 Citations |
1 | A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. (Asare EA, Wang TS, Winchester DP, Mallin K, Kebebew E, Sturgeon C) Surgery 2014 Dec;156(6):1378-85; discussion 1385-6 35 Citations |
1 | Is central lymph node dissection necessary for parathyroid carcinoma? (Hsu KT, Sippel RS, Chen H, Schneider DF) Surgery 2014 Dec;156(6):1336-41; discussion 1341 64 Citations |
4 | Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. (Santana-Davila R, Devisetty K, Szabo A, Sparapani R, Arce-Lara C, Gore EM, Moran A, Williams CD, Kelley MJ, Whittle J) J Clin Oncol 2015 Feb 20;33(6):567-74 105 Citations |
2 | Is local resection adequate for T1 stage ampullary cancer? (Amini A, Miura JT, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC, Turaga KK) HPB (Oxford) 2015 Jan;17(1):66-71 30 Citations |
1 | Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. (Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA) J Thorac Oncol 2015 Mar;10(3):462-71 90 Citations |
1 | Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. (Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R) Oncotarget 2014 Nov 15;5(21):10280-92 49 Citations |
1 | Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. (Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT) J Clin Oncol 2014 Dec 01;32(34):3858-66 347 Citations |
1 | Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic. (Jardim DL, Tang C, Gagliato Dde M, Falchook GS, Hess K, Janku F, Fu S, Wheler JJ, Zinner RG, Naing A, Tsimberidou AM, Holla V, Li MM, Roy-Chowdhuri S, Luthra R, Salgia R, Kurzrock R, Meric-Bernstam F, Hong DS) Clin Cancer Res 2014 Dec 15;20(24):6336-45 72 Citations |
1 | Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group. (Burke MJ, Ahern C, Weigel BJ, Poirier JT, Rudin CM, Chen Y, Cripe TP, Bernhardt MB, Blaney SM) Pediatr Blood Cancer 2015 May;62(5):743-50 57 Citations |
1 | Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report. (Trippett TM, Schwartz CL, Guillerman RP, Gamis AS, Gardner S, Hogan S, London WB, Chen L, de Alarcon P) Pediatr Blood Cancer 2015 Jan;62(1):60-4 22 Citations |
1 | Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision. (Walters LL, Pang JC, Zhao L, Jorns JM) Histopathology 2015 Mar;66(4):577-86 7 Citations |
1 | The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma. (Nagle SJ, Chong EA, Chekol S, Shah NN, Nasta SD, Glatstein E, Plastaras JP, Torigian DA, Schuster SJ, Svoboda J) Cancer Med 2015 Jan;4(1):7-15 17 Citations |
1 | A planning comparison of 7 irradiation options allowed in RTOG 1005 for early-stage breast cancer. (Chen GP, Liu F, White J, Vicini FA, Freedman GM, Arthur DW, Li XA) Med Dosim 2015;40(1):21-5 22 Citations |
1 | Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). (Jayakrishnan TT, Zacharias AJ, Sharma A, Pappas SG, Gamblin TC, Turaga KK) World J Surg Oncol 2014 Aug 21;12:270 48 Citations |
1 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. (Helm JH, Miura JT, Glenn JA, Marcus RK, Larrieux G, Jayakrishnan TT, Donahue AE, Gamblin TC, Turaga KK, Johnston FM) Ann Surg Oncol 2015 May;22(5):1686-93 192 Citations |
1 | Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. (Kim SY, Le Rademacher J, Antin JH, Anderlini P, Ayas M, Battiwalla M, Carreras J, Kurtzberg J, Nakamura R, Eapen M, Deeg HJ) Haematologica 2014 Dec;99(12):1868-75 19 Citations |
1 | Surgical resection of synchronously metastatic adrenocortical cancer. (Dy BM, Strajina V, Cayo AK, Richards ML, Farley DR, Grant CS, Harmsen WS, Evans DB, Grubbs EG, Bible KC, Young WF, Perrier ND, Que FG, Nagorney DM, Lee JE, Thompson GB) Ann Surg Oncol 2015 Jan;22(1):146-51 37 Citations |
1 | Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis. (Pandanaboyana S, White A, Pathak S, Hidalgo EL, Toogood G, Lodge JP, Prasad KR) Ann Surg Oncol 2015 Jan;22(1):173-9 29 Citations |
1 | Surgical management of advanced gastrointestinal stromal tumors: an international multi-institutional analysis of 158 patients. (Bischof DA, Kim Y, Blazer DG 3rd, Behman R, Karanicolas PJ, Law CH, Quereshy FA, Maithel SK, Gamblin TC, Bauer TW, Pawlik TM) J Am Coll Surg 2014 Sep;219(3):439-49 27 Citations |
1 | Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? (Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR) Eur J Gastroenterol Hepatol 2014 Sep;26(9):1047-54 46 Citations |
1 | Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients. (Takeuchi S, Balachandran A, Habra MA, Phan AT, Bassett RL Jr, Macapinlac HA, Chuang HH) Eur J Nucl Med Mol Imaging 2014 Nov;41(11):2066-73 34 Citations |
1 | Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast. (Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG, Pang JC) Ann Surg Oncol 2014 Dec;21(13):4152-8 14 Citations |
1 | ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases. (Expert Panel on Radiation Oncology-Brain Metastases, Lo SS, Gore EM, Bradley JD, Buatti JM, Germano I, Ghafoori AP, Henderson MA, Murad GJ, Patchell RA, Patel SH, Robbins JR, Robins HI, Vassil AD, Wippold FJ 2nd, Yunes MJ, Videtic GM) J Palliat Med 2014 Aug;17(8):880-6 26 Citations |
1 | Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. (Zhu AX, Borger DR, Kim Y, Cosgrove D, Ejaz A, Alexandrescu S, Groeschl RT, Deshpande V, Lindberg JM, Ferrone C, Sempoux C, Yau T, Poon R, Popescu I, Bauer TW, Gamblin TC, Gigot JF, Anders RA, Pawlik TM) Ann Surg Oncol 2014 Nov;21(12):3827-34 125 Citations |
1 | Current trends in the management of malignant peritoneal mesothelioma. (Miura JT, Johnston FM, Gamblin TC, Turaga KK) Ann Surg Oncol 2014 Nov;21(12):3947-53 39 Citations |
1 | Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. (Spolverato G, Ejaz A, Kim Y, Sotiropoulos GC, Pau A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh W, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Gigot JF, Mentha G, Pawlik TM) J Gastrointest Surg 2014 Jul;18(7):1284-91 61 Citations |
7 | 3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014;13(4):319-25 28 Citations |
1 | Impact of sociodemographic factors on the radiotherapeutic management of lung cancer: Results of a Quality Research in Radiation Oncology survey. (Rengan R, Ho A, Owen JB, Komaki R, Khalid N, Wilson JF, Movsas B) Pract Radiat Oncol 2014;4(3):e167-e179 2 Citations |
1 | Hospital variation in sphincter preservation for elderly rectal cancer patients. (Dodgion CM, Neville BA, Lipsitz SR, Schrag D, Breen E, Zinner MJ, Greenberg CC) J Surg Res 2014 Sep;191(1):161-8 12 Citations |
1 | Tumor enucleation vs sharp excision in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes. (Mukkamala A, Allam CL, Ellison JS, Hafez KS, Miller DC, Montgomery JS, Weizer AZ, Wolf JS Jr) Urology 2014 Jun;83(6):1294-9 47 Citations |
1 | Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. (Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG) World J Surg 2014 Jun;38(6):1318-27 44 Citations |
1 | Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. (Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ) Head Neck 2015 Jun;37(6):777-82 58 Citations |
1 | A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. (Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Popescu I, Gigot JF, Mentha G, Feng S, Pawlik TM) JAMA Surg 2014 May;149(5):432-8 278 Citations |
1 | Acr appropriateness Criteria management of vaginal cancer. (Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK) Oncology (Williston Park) 2013 Nov;27(11):1166-73 21 Citations |
1 | Comorbidity burden and guideline-concordant care for breast cancer. (Kimmick G, Fleming ST, Sabatino SA, Wu XC, Hwang W, Wilson JF, Lund MJ, Cress R, Anderson RT, Centers for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group) J Am Geriatr Soc 2014 Mar;62(3):482-8 32 Citations |
1 | Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. (Prabhu RS, Hanasoge S, Magliocca KR, Moeller BJ, Milas ZL, Hall WA, El-Deiry M, Wadsworth JT, Higgins KA, Beitler JJ) Cancer 2014 May 15;120(10):1499-506 51 Citations |
1 | Optimizing rectal cancer management: analysis of current evidence. (Abbas MA, Chang GJ, Read TE, Rothenberger DA, Garcia-Aguilar J, Peters W, Monson JR, Sharma A, Dietz DW, Madoff RD, Fleshman JW, Greene FL, Wexner SD, Remzi FH, Consortium for Optimizing Surgical Treatment of Rectal Cancer) Dis Colon Rectum 2014 Feb;57(2):252-9 26 Citations |
1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 39 Citations |
1 | Soft, multilobed exophytic mass in a woman in her 50s. (Piette EW, Sobanko JF, Wanat KA) JAMA Dermatol 2014 Mar;150(3):323-4 1 Citation |
4 | Surgeon specialization and use of sentinel lymph node biopsy for breast cancer. (Yen TW, Laud PW, Sparapani RA, Nattinger AB) JAMA Surg 2014 Feb;149(2):185-92 28 Citations |
1 | Does histology predict outcome for malignant vascular tumors of the liver? (Groeschl RT, Miura JT, Oshima K, Gamblin TC, Turaga KK) J Surg Oncol 2014 Apr;109(5):483-6 36 Citations |
1 | The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study. (Ramsdale E, Polite B, Hemmerich J, Bylow K, Kindler HL, Mohile S, Dale W) J Am Geriatr Soc 2013 Nov;61(11):2043-4 11 Citations |
1 | Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer. (Wang B, Zhao B, North P, Kong A, Huang J, Miao QR) PLoS One 2013;8(11):e78083 38 Citations |
1 | Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. (Toh E, Wilson J, Sebag-Montefiore D, Botterill I) Colorectal Dis 2014 Mar;16(3):O90-7 31 Citations |
1 | Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations. (Ganesan P, Janku F, Naing A, Hong DS, Tsimberidou AM, Falchook GS, Wheler JJ, Piha-Paul SA, Fu S, Stepanek VM, Lee JJ, Luthra R, Overman MJ, Kopetz ES, Wolff RA, Kurzrock R) Mol Cancer Ther 2013 Dec;12(12):2857-63 39 Citations |
1 | Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial. (Gonzalez-Angulo AM, Meric-Bernstam F, Chawla S, Falchook G, Hong D, Akcakanat A, Chen H, Naing A, Fu S, Wheler J, Moulder S, Helgason T, Li S, Elias I, Desai N, Kurzrock R) Clin Cancer Res 2013 Oct 01;19(19):5474-84 69 Citations |
1 | RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients. (Kachnic LA, Pugh SL, Tai P, Smith M, Gore E, Shah AB, Martin AG, Kim HE, Nabid A, Lawton CA) Prostate Cancer Prostatic Dis 2013 Dec;16(4):382-6 29 Citations |
2 | Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. (Miura JT, Evans DB, Pappas SG, Gamblin TC, Turaga KK) Ann Surg Oncol 2013 Dec;20(13):4338-47 7 Citations |
1 | Managing malignant melanoma. (Dzwierzynski WW) Plast Reconstr Surg 2013 Sep;132(3):446e-460e 50 Citations |
1 | Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutations. (Wheler JJ, Tsimberidou AM, Falchook GS, Zinner RG, Hong DS, Fok JY, Fu S, Piha-Paul SA, Naing A, Kurzrock R) Mol Cancer Ther 2013 Oct;12(10):2167-75 33 Citations |
1 | Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. (Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG) Pediatr Blood Cancer 2014 Feb;61(2):269-75 30 Citations |
1 | MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. (Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce CM, Chakravarti A, Jin VX, Lautenschlaeger T) Clin Cancer Res 2013 Oct 01;19(19):5423-33 96 Citations |
4 | A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position. (Bergom C, Prior P, Kainz K, Morrow NV, Ahunbay EE, Walker A, Allen Li X, White J) Radiother Oncol 2013 Aug;108(2):215-9 19 Citations |
1 | ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. (Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Am J Clin Oncol 2013 Aug;36(4):415-22 16 Citations |
1 | TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. (Schabath MB, Giuliano AR, Thompson ZJ, Amankwah EK, Gray JE, Fenstermacher DA, Jonathan KA, Beg AA, Haura EB) Carcinogenesis 2013 Nov;34(11):2525-30 17 Citations |
4 | Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. (Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, Maharaj D, Munker R, Phillips GL, Rizzieri DA, Rowlings PA, Saber W, Satwani P, Waller EK, Maloney DG, Montoto S, Laport GG, Vose JM, Lazarus HM, Hari PN) Br J Haematol 2013 Sep;162(5):648-56 23 Citations |
1 | Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients. (Schmidt B, Look-Hong N, Maduekwe UN, Chang K, Hong TS, Kwak EL, Lauwers GY, Rattner DW, Mullen JT, Yoon SS) Ann Surg Oncol 2013 Oct;20(11):3512-8 29 Citations |
1 | D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging. (Schmidt B, Chang KK, Maduekwe UN, Look-Hong N, Rattner DW, Lauwers GY, Mullen JT, Yang HK, Yoon SS) Ann Surg Oncol 2013 Sep;20(9):2991-9 21 Citations |
1 | Posterior reversible encephalopathy syndrome: more than meets the eye. (Munoz J, Kumar VA, Hamilton J, Pasche LJ, Langford LA, Taggart MW, Kamiya-Matsuoka C, Tummala S, Moulder S, Kurzrock R) J Clin Oncol 2013 Jul 10;31(20):e360-3 9 Citations |
1 | Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. (Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer 2013 Sep 01;119(17):3148-55 99 Citations |
1 | Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint. (Groeschl RT, Gamblin TC, Turaga KK) Ann Surg Oncol 2013 Oct;20(11):3591-5 20 Citations |
1 | A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease. (Kurzrock R, Voorhees PM, Casper C, Furman RR, Fayad L, Lonial S, Borghaei H, Jagannath S, Sokol L, Usmani SZ, van de Velde H, Qin X, Puchalski TA, Hall B, Reddy M, Qi M, van Rhee F) Clin Cancer Res 2013 Jul 01;19(13):3659-70 179 Citations |
1 | Cognitive adaptation theory and quality of life in late-stage cancer patients. (Christianson HF, Weis JM, Fouad NA) J Psychosoc Oncol 2013;31(3):266-81 10 Citations |
1 | The financial burden of reexcising incompletely excised soft tissue sarcomas: a cost analysis. (Alamanda VK, Delisca GO, Mathis SL, Archer KR, Ehrenfeld JM, Miller MW, Homlar KC, Halpern JL, Schwartz HS, Holt GE) Ann Surg Oncol 2013 Sep;20(9):2808-14 37 Citations |
5 | Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? (Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB) HPB (Oxford) 2014 Jan;16(1):70-4 23 Citations |
1 | Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. (Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, Chauncey TR, Pulsipher MA, Petersen FB, Sahebi F, Agura ED, Hari P, Bruno B, McSweeney PA, Maris MB, Maziarz RT, Langston AA, Bethge W, Vindeløv L, Franke GN, Laport GG, Yeager AM, Hübel K, Deeg HJ, Georges GE, Flowers ME, Martin PJ, Mielcarek M, Woolfrey AE, Maloney DG, Sandmaier BM) J Clin Oncol 2013 Apr 20;31(12):1530-8 176 Citations |
1 | 11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction. (Haseebuddin M, Dehdashti F, Siegel BA, Liu J, Roth EB, Nepple KG, Siegel CL, Fischer KC, Kibel AS, Andriole GL, Miller TR) J Nucl Med 2013 May;54(5):699-706 69 Citations |
1 | Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much? (Turaga KK, Pappas S, Gamblin TC) Ann Surg Oncol 2013 Apr;20(4):1063-7 49 Citations |
1 | The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. (Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB) Ann Surg Oncol 2013 Dec;20 Suppl 3:S500-8 56 Citations |
1 | Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. (El-Gazzaz G, Sourianarayanane A, Menon KV, Sanabria J, Hashimoto K, Quintini C, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) Hepatobiliary Pancreat Dis Int 2013 Feb;12(1):34-41 |
1 | Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. (Padia SA, Shivaram G, Bastawrous S, Bhargava P, Vo NJ, Vaidya S, Valji K, Harris WP, Hippe DS, Kogut MJ) J Vasc Interv Radiol 2013 Mar;24(3):301-6 81 Citations |
1 | A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. (Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS) J Urol 2013 Jul;190(1):102-8 52 Citations |
1 | A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies. (Naing A, Cohen R, Dy GK, Hong DS, Dyster L, Hangauer DG, Kwan R, Fetterly G, Kurzrock R, Adjei AA) Invest New Drugs 2013 Aug;31(4):967-73 27 Citations |
1 | Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. (Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB) Am J Clin Oncol 2014 Feb;37(1):57-62 6 Citations |
1 | Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies. (Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G, Saussez S) J Cancer Res Clin Oncol 2013 May;139(5):727-37 30 Citations |
1 | Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. (Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC) Int J Radiat Oncol Biol Phys 2013 May 01;86(1):102-7 31 Citations |
3 | Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. (Bedi M, King DM, Charlson J, Whitfield R, Hackbarth DA, Zambrano EV, Wang D) Am J Clin Oncol 2014 Jun;37(3):272-7 15 Citations |
1 | Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey. (Komaki R, Khalid N, Langer CJ, Kong FM, Owen JB, Crozier CL, Wilson JF, Wei X, Movsas B) Int J Radiat Oncol Biol Phys 2013 Mar 15;85(4):1082-9 47 Citations |
2 | Current staging systems for pancreatic cancer. (Appel BL, Tolat P, Evans DB, Tsai S) Cancer J 2012;18(6):539-49 63 Citations |
1 | A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors. (Hong DS, Choe JH, Naing A, Wheler JJ, Falchook GS, Piha-Paul S, Moulder SL, George GC, Choe JM, Strauss LC, Gallick GE, Kurzrock R) Invest New Drugs 2013 Aug;31(4):918-26 29 Citations |
2 | Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. (Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin TC) Ann Surg Oncol 2013 Apr;20(4):1230-9 9 Citations |
1 | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. (Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ 3rd, Bartlett DL, Choudry HA) Ann Surg Oncol 2013 Feb;20(2):506-14 46 Citations |
1 | Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis. (Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, Groeschl R, Hyder O, Kooby DA, Blazer D 3rd, Choti MA, Wolfgang CL, Gamblin TC, Hawkins WG, Maithel SK, Pawlik TM) Ann Surg Oncol 2012 Oct;19(11):3351-60 70 Citations |
1 | Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. (Hu L, Wu C, Zhao X, Heist R, Su L, Zhao Y, Han B, Cao S, Chu M, Dai J, Dong J, Shu Y, Xu L, Chen Y, Wang Y, Lu F, Jiang Y, Yu D, Chen H, Tan W, Ma H, Chen J, Jin G, Wu T, Lu D, Christiani DC, Lin D, Hu Z, Shen H) Clin Cancer Res 2012 Oct 01;18(19):5507-14 52 Citations |
1 | ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. (Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK) Am J Clin Oncol 2012 Aug;35(4):399-405 14 Citations |
1 | Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. (Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL) J Clin Oncol 2012 Jul 20;30(21):2635-40 67 Citations |
1 | Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies. (Kurzrock R, Goel S, Wheler J, Hong D, Fu S, Rezai K, Morgan-Linnell SK, Urien S, Mani S, Chaudhary I, Ghalib MH, Buchbinder A, Lokiec F, Mulcahy M) Cancer 2012 Dec 15;118(24):6144-51 42 Citations |
1 | Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. (Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F) Cancer 2012 Dec 15;118(24):6287-96 36 Citations |
1 | Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. (Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H) Int J Radiat Oncol Biol Phys 2012 Oct 01;84(2):456-63 89 Citations |
1 | Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. (Kosinski L, Habr-Gama A, Ludwig K, Perez R) CA Cancer J Clin 2012;62(3):173-202 84 Citations |
1 | Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. (Sourianarayanane A, El-Gazzaz G, Sanabria JR, Menon KV, Quintini C, Hashimoto K, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) HPB (Oxford) 2012 May;14(5):325-32 12 Citations |
1 | Ex vivo evaluation of preoperatively treated rectal cancer specimens of patients undergoing radical resection. (de la Fuente SG, Ludwig KA, Tyler DS, Mantyh CR) Ann Surg Oncol 2012 Jun;19(6):1954-8 2 Citations |
1 | Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. (Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW, Lauwers GY, Yoon SS) Ann Surg 2012 Mar;255(3):478-85 171 Citations |
1 | Importance of histologic subtype in the staging of appendiceal tumors. (Turaga KK, Pappas SG, Gamblin T) Ann Surg Oncol 2012 May;19(5):1379-85 148 Citations |
1 | Concepts of regional therapies for advanced malignancy. (Gamblin T, Alexander H, Edwards R, Bartlett DL) Ann Surg Oncol 2012 May;19(5):1371-2 2 Citations |
1 | Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. (Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R) PLoS One 2012;7(1):e29330 86 Citations |
1 | Anticoagulation-induced severe bleeding in a patient receiving bevacizumab therapy. (Munoz J, Hong D, Kurzrock R) Int J Hematol 2012 Jan;95(1):1-2 2 Citations |
1 | ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. (Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR, American College of Radiology (ACR)) Gynecol Oncol 2012 Apr;125(1):256-62 14 Citations |
1 | Serum profiling to distinguish early- and late-stage ovarian cancer patients from disease-free individuals. (Hocker JR, Bishop EA, Lightfoot SA, Lerner MR, Peyton MD, Brackett DJ, Hanas RJ, McMeekin DS, Walker JL, Hanas JS) Cancer Invest 2012 Feb;30(2):189-97 6 Citations |
1 | Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? (Nugent EK, Bishop EA, Mathews CA, Moxley KM, Tenney M, Mannel RS, Walker JL, Moore KN, Landrum LM, McMeekin DS) Gynecol Oncol 2012 Apr;125(1):94-8 53 Citations |
1 | Trends in anemia management in lung and colon cancer patients in the US Department of Veterans Affairs, 2002-2008. (Tarlov E, Stroupe KT, Lee TA, Weichle TW, Zhang QL, Michaelis LC, Ozer H, Browning MM, Hynes DM) Support Care Cancer 2012 Aug;20(8):1649-57 14 Citations |
1 | Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. (Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD) J Natl Cancer Inst 2011 Oct 05;103(19):1452-60 1001 Citations |
1 | Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network. (Kenkre VP, Long WL, Eickhoff JC, Blank JH, McFarland TA, Bottner W, Rezazedeh H, Werndli JE, Bailey HH, Kahl BS) Leuk Lymphoma 2011 Sep;52(9):1675-80 37 Citations |
1 | Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma. (Berger AC, Fierro M, Kairys JC, Berd D, Sato T, Andrel J, Hyslop T, Mastrangelo MJ) J Surg Oncol 2012 Jan;105(1):15-20 14 Citations |
1 | Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? (Yoo DC, Dupuy DE, Hillman SL, Fernando HC, Rilling WS, Shepard JA, Siegel BA) AJR Am J Roentgenol 2011 Aug;197(2):334-40 44 Citations |
2 | Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2012 Mar 15;82(4):1367-75 66 Citations |
1 | Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. (Naing A, Kurzrock R, Burger A, Gupta S, Lei X, Busaidy N, Hong D, Chen HX, Doyle LA, Heilbrun LK, Rohren E, Ng C, Chandhasin C, LoRusso P) Clin Cancer Res 2011 Sep 15;17(18):6052-60 105 Citations |
1 | Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. (Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, Freeman RB) Liver Transpl 2011 Oct;17 Suppl 2:S81-9 49 Citations |
1 | Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. (Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H) Cancer 2012 Jan 01;118(1):268-77 70 Citations |
1 | Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. (de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Gamblin TC, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Schulick RD, Choti MA, Gigot JF, Mentha G, Pawlik TM) J Clin Oncol 2011 Aug 10;29(23):3140-5 604 Citations |
1 | Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. (Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW) Ann Surg Oncol 2011 Dec;18(13):3615-22 18 Citations |
1 | How low is low? Evolving approaches to sphincter-sparing resection techniques. (Ludwig K, Kosinski L) Semin Radiat Oncol 2011 Jul;21(3):185-95 3 Citations |
1 | Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213. (Gore E, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H) Clin Lung Cancer 2011 Mar;12(2):125-30 25 Citations |
1 | ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II. (Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ) J Am Coll Radiol 2011 May;8(5):302-8 2 Citations |
1 | An evidence-based review of the surgical treatment of gastric adenocarcinoma. (Maduekwe UN, Yoon SS) J Gastrointest Surg 2011 May;15(5):730-41 9 Citations |
1 | MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese. (Dong J, Ren B, Hu Z, Chen J, Hu L, Dai J, Jin G, Xu L, Shen H) Mol Carcinog 2011 Jun;50(6):433-8 19 Citations |
1 | Impact of neoadjuvant chemotherapy on breast reconstruction. (Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC) Cancer 2011 Jul 01;117(13):2833-41 43 Citations |
1 | ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. (Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Int J Radiat Oncol Biol Phys 2011 Nov 01;81(3):609-14 60 Citations |
1 | Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. (Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ) Arch Surg 2010 Dec;145(12):1158-63 113 Citations |
4 | CD23 expression in follicular lymphoma: clinicopathologic correlations. (Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH) Am J Clin Pathol 2011 Jan;135(1):46-53 31 Citations |
1 | The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma. (Bishop EA, Lengyel ER, Yamada SD, Montag A, Temkin SM) Gynecol Oncol 2011 Apr;121(1):218-23 14 Citations |
1 | Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer. (Tsimberidou AM, Akerley W, Schabel MC, Hong DS, Uehara C, Chhabra A, Warren T, Mather GG, Evans BA, Woodland DP, Swabb EA, Kurzrock R) Mol Cancer Ther 2010 Dec;9(12):3410-9 47 Citations |
1 | Sentinel lymph node dissection is technically feasible in older breast cancer patients. (Valero V 3rd, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA) Clin Breast Cancer 2010 Dec 01;10(6):477-82 4 Citations |
1 | Diagnostic utility of snail in metaplastic breast carcinoma. (Nassar A, Sookhan N, Santisteban M, Bryant SC, Boughey JC, Giorgadze T, Degnim A) Diagn Pathol 2010 Nov 26;5:76 21 Citations |
1 | Explaining place-based colorectal cancer health disparities: evidence from a rural context. (Beyer KM, Comstock S, Seagren R, Rushton G) Soc Sci Med 2011 Feb;72(3):373-82 30 Citations |
1 | Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. (Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA) Obstet Gynecol 2010 Nov;116(5):1150-7 41 Citations |
1 | Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. (Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, WHI Investigators) JAMA 2010 Oct 20;304(15):1684-92 453 Citations |
1 | Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. (Cludts S, Decaestecker C, Johnson B, Lechien J, Leroy X, Kindt N, Kaltner H, André S, Gabius HJ, Saussez S) Anticancer Res 2010 Sep;30(9):3313-9 15 Citations |
1 | Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival. (Dai J, Jin G, Dong J, Chen Y, Xu L, Hu Z, Shen H) J Thorac Oncol 2010 Nov;5(11):1748-54 |
1 | Interleukin-16 as a marker of Sézary syndrome onset and stage. (Richmond J, Tuzova M, Parks A, Adams N, Martin E, Tawa M, Morrison L, Chaney K, Kupper TS, Curiel-Lewandrowski C, Cruikshank W) J Clin Immunol 2011 Feb;31(1):39-50 24 Citations |
1 | Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. (Fuller CK, Charlson JA, Dankle SK, Russell TJ) J Am Acad Dermatol 2010 Oct;63(4):e83-4 35 Citations |
4 | Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. (Ellingson BM, Malkin MG, Rand SD, LaViolette PS, Connelly JM, Mueller WM, Schmainda KM) J Neurooncol 2011 Mar;102(1):95-103 56 Citations |
2 | Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. (Evans DB, Erickson BA, Ritch P) Ann Surg Oncol 2010 Nov;17(11):2803-5 58 Citations |
1 | Relation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Lundy D, Bernstein M, McBreen C, Santa D, Campanelli A, Kelchner L, Klaben B, Discekici-Harris M) Head Neck 2011 Jun;33(6):774-9 17 Citations |
1 | Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor. (Christian B, Zhao W, Hamadani M, Sotomayor EM, Navarro W, Devine SM, Racke F, Blum KA) J Clin Oncol 2010 Nov 01;28(31):e629-32 30 Citations |
1 | High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H) Cancer Epidemiol Biomarkers Prev 2010 Oct;19(10):2598-604 57 Citations |
1 | International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. (Augestad KM, Lindsetmo RO, Stulberg J, Reynolds H, Senagore A, Champagne B, Heriot AG, Leblanc F, Delaney CP, International Rectal Cancer Study Group (IRCSG)) World J Surg 2010 Nov;34(11):2689-700 83 Citations |
1 | Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma? (Crosby MA, Tward JD, Szabo A, Lee CM, Gaffney DK) Am J Clin Oncol 2010 Aug;33(4):364-9 19 Citations |
1 | Higher physician density is associated with lower incidence of late-stage colorectal cancer. (Ananthakrishnan AN, Hoffmann RG, Saeian K) J Gen Intern Med 2010 Nov;25(11):1164-71 61 Citations |
2 | The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1394-9 28 Citations |
1 | High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H) Clin Cancer Res 2010 Jul 15;16(14):3734-42 35 Citations |
1 | Tissue microarrays: one size does not fit all. (Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, Kwon ED) Diagn Pathol 2010 Jul 07;5:48 39 Citations |
2 | Carboplatin and docetaxel-induced acute pancreatitis: brief report. (Singh V, Devata S, Cheng YC) Int J Clin Oncol 2010 Dec;15(6):642-4 12 Citations |
1 | Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. (Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik TM) Ann Surg Oncol 2010 Dec;17(12):3129-36 343 Citations |
1 | A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. (Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) Int J Radiat Oncol Biol Phys 2010 Jun 01;77(2):367-72 111 Citations |
2 | Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. (Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS) Bone Marrow Transplant 2011 Jan;46(1):70-6 68 Citations |
1 | Antitumor effects on primary tumor and metastatic lymph nodes by superselective intra-arterial concurrent chemoradiotherapy for oral cancer. (Uehara M, Shiraishi T, Tobita T, Nonaka M, Asahina I) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Aug;110(2):172-7 8 Citations |
1 | Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. (Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) J Clin Oncol 2010 May 10;28(14):2475-80 126 Citations |
1 | Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. (Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW) J Clin Oncol 2010 Apr 20;28(12):2108-13 259 Citations |
2 | Stereotactic body radiation therapy for inoperable early stage lung cancer. (Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H) JAMA 2010 Mar 17;303(11):1070-6 2048 Citations |
2 | Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. (Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD) J Clin Oncol 2010 Apr 10;28(11):1888-95 104 Citations |
1 | TP53, MDM2, NQO1, and susceptibility to cervical cancer. (Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS) Cancer Epidemiol Biomarkers Prev 2010 Mar;19(3):755-61 50 Citations |
1 | Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. (Yoon SS, Chen YL, Kirsch DG, Maduekwe UN, Rosenberg AE, Nielsen GP, Sahani DV, Choy E, Harmon DC, DeLaney TF) Ann Surg Oncol 2010 Jun;17(6):1515-29 98 Citations |
1 | Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. (Stinchcombe TE, Gore EM) Oncologist 2010;15(2):187-95 76 Citations |
1 | Juice plus or toxicity plus. (Naing A, Aaron J, Kurzrock R) Am J Med 2010 Jan;123(1):e1-2 3 Citations |
1 | New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. (Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS) Ann Surg Oncol 2010 May;17(5):1267-77 54 Citations |
1 | "Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer. (Zighelboim I, Kizer N, Taylor NP, Case AS, Gao F, Thaker PH, Rader JS, Massad LS, Mutch DG, Powell MA) Gynecol Oncol 2010 Mar;116(3):370-3 51 Citations |
1 | 18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer. (Showalter TN, Miller TR, Huettner P, Rader J, Grigsby PW) Int J Gynecol Cancer 2009 Nov;19(8):1412-4 32 Citations |
1 | Staged excision of lentigo maligna and lentigo maligna melanoma: a 10-year experience. (Bosbous MW, Dzwierzynski WW, Neuburg M) Plast Reconstr Surg 2009 Dec;124(6):1947-1955 62 Citations |
1 | Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. (Cardinal J, de Vera ME, Marsh JW, Steel JL, Geller DA, Fontes P, Nalesnik M, Gamblin TC) Arch Surg 2009 Nov;144(11):1035-9 53 Citations |
1 | Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer. (Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS) Gynecol Oncol 2010 Mar;116(3):539-43 33 Citations |
1 | Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. (Nugent EK, Case AS, Hoff JT, Zighelboim I, DeWitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS) Gynecol Oncol 2010 Mar;116(3):438-41 56 Citations |
1 | Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. (Young AL, Prasad KR, Toogood GJ, Lodge JP) J Hepatobiliary Pancreat Sci 2010 Jul;17(4):497-504 56 Citations |
2 | Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. (Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, Lee JE) Ann Surg Oncol 2010 Jan;17(1):263-70 132 Citations |
1 | Lymphoma in adolescents and young adults. (Jaglowski SM, Linden E, Termuhlen AM, Flynn JM) Semin Oncol 2009 Oct;36(5):381-418 64 Citations |
1 | Optimal treatment for hepatocellular carcinoma in the cirrhotic liver. (White SA, Manas DM, Farid SG, Prasad KR) Ann R Coll Surg Engl 2009 Oct;91(7):545-50 1 Citation |
1 | Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry. (Conway EJ, Wen J, Feng Y, Mo A, Huang WT, Keever-Taylor CA, Hari P, Vesole DH, Chang CC) Arch Pathol Lab Med 2009 Oct;133(10):1594-9 9 Citations |
1 | Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? (Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC) Ann Surg Oncol 2009 Dec;16(12):3308-15 30 Citations |
1 | NCCN Clinical Practice Guidelines in Oncology: colon cancer. (Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2009 Sep;7(8):778-831 312 Citations |
1 | Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. (Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND) Ann Surg Oncol 2009 Nov;16(11):3146-53 33 Citations |
3 | Soft-tissue sarcoma metastases identified on abdomen and pelvis CT imaging. (King DM, Hackbarth DA, Kilian CM, Carrera GF) Clin Orthop Relat Res 2009 Nov;467(11):2838-44 23 Citations |
1 | Salvage transplantation for stage IVa hepatocellular carcinoma, what are the guidelines? (Goldsmith PJ, Toogood GJ, Lodge JP, Prasad KR) Clin Transplant 2009;23(5):581 1 Citation |
1 | The value of perioperative imaging in patients with uterine sarcomas. (Nugent EK, Zighelboim I, Case AS, Gao F, Thaker PH, Rader JS, Mutch DG, Massad LS) Gynecol Oncol 2009 Oct;115(1):37-40 9 Citations |
1 | The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. (Massad LS, Jeronimo J, Katki HA, Schiffman M, National Institutes of Health/American Society for Colposcopy and Cervical Pathology Research Group) J Low Genit Tract Dis 2009 Jul;13(3):137-44 126 Citations |
1 | Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. (Herbst RS, Hong D, Chap L, Kurzrock R, Jackson E, Silverman JM, Rasmussen E, Sun YN, Zhong D, Hwang YC, Evelhoch JL, Oliner JD, Le N, Rosen LS) J Clin Oncol 2009 Jul 20;27(21):3557-65 222 Citations |
1 | Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? (Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, Weber SM, Wilson SD, Howard TJ, Talamonti MS, Rikkers LF) J Gastrointest Surg 2009 Sep;13(9):1692-8 101 Citations |
1 | A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. (Moulder S, Dhillon N, Ng C, Hong D, Wheler J, Naing A, Tse S, La Paglia A, Dorr R, Hersh E, Boytim M, Kurzrock R) Invest New Drugs 2010 Oct;28(5):634-40 31 Citations |
1 | Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. (Chen W, Wang S, Tian T, Bai J, Hu Z, Xu Y, Dong J, Chen F, Wang X, Shen H) Eur J Hum Genet 2009 Dec;17(12):1668-75 88 Citations |
1 | ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. (Zighelboim I, Schmidt AP, Gao F, Thaker PH, Powell MA, Rader JS, Gibb RK, Mutch DG, Goodfellow PJ) J Clin Oncol 2009 Jul 01;27(19):3091-6 54 Citations |
1 | Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma. (Sargin SY, Ekmekcioglu O, Arpali E, Altinel M, Voyvoda B) Urol Int 2009;82(3):324-9 9 Citations |
1 | Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. (Brooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, Wall LL) Gynecol Oncol 2009 Jul;114(1):75-9 42 Citations |
1 | Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. (Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD) Ann Surg Oncol 2009 Jul;16(7):1736-44 187 Citations |
1 | Method of breast cancer presentation and depressed mood 1 year after diagnosis in women with locally advanced disease. (Roth EB, Jeffe DB, Margenthaler JA, Aft RL) Ann Surg Oncol 2009 Jun;16(6):1637-41 2 Citations |
2 | Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. (Hari PN, Zhang MJ, Roy V, Pérez WS, Bashey A, To LB, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela-Ojeda J, Weisdorf D, Vesole D) Leukemia 2009 Aug;23(8):1528-34 78 Citations |
1 | Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study. (Fortune BE, Li X, Kosuri KV, Weatherby LM, Thomas JP, Bekaii-Saab TS) Oncology 2009;76(5):333-7 21 Citations |
1 | Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB) Arch Surg 2009 Mar;144(3):216-21 89 Citations |
1 | Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. (Maduekwe UN, Hornicek FJ, Springfield DS, Raskin KA, Harmon DC, Choy E, Rosenberg AE, Nielsen GP, DeLaney TF, Chen YL, Ott MJ, Yoon SS) Ann Surg Oncol 2009 May;16(5):1356-63 55 Citations |
1 | Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation. (Yi NJ, Suh KS, Kim T, Kim J, Shin WY, Lee KU) Oncology 2008;75 Suppl 1:124-8 23 Citations |
1 | The impact of extramedullary disease at presentation on the outcome of myeloma. (Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, Potter MN, Ethell ME, Shaw BE, Morgan GJ) Leuk Lymphoma 2009 Feb;50(2):230-5 99 Citations |
1 | [New data in staging and prognosis of bronchopulmonary carcinoma. Part II: volumetric analysis of pulmonary nodules]. (Ioachimescu O, Corlan E) Pneumologia 2008;57(4):209-14, 216-20 |
1 | Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation. (Fowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS) Gynecol Oncol 2009 Mar;112(3):553-7 16 Citations |
1 | A phase I study of an oral simulated FOLFOX with high dose capecitabine. (Mulkerin D, LoConte NK, Holen KD, Thomas JP, Alberti D, Marnocha R, Kolesar J, Eickhoff J, Oliver K, Feierabend C, Wilding G) Invest New Drugs 2009 Oct;27(5):461-8 7 Citations |
1 | Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells. (Bass R, Perry B, Langenstroer P, Thrasher JB, Dennis KL, Tawfik O, Holzbeierlein J) J Urol 2009 Feb;181(2):615-9; discussion 619-20 24 Citations |
1 | Surgical management of hepatocellular carcinoma: is the jury still out? (Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR) Surg Oncol 2009 Dec;18(4):298-321 53 Citations |
1 | Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides. (Sun G, Berthelot C, Li Y, Glass DA 2nd, George D, Pandya A, Kurzrock R, Duvic M) J Am Acad Dermatol 2009 Feb;60(2):231-5 64 Citations |
1 | Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H) Clin Cancer Res 2008 Nov 01;14(21):7043-9 89 Citations |
1 | Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. (Brooks RA, Rader JS, Dehdashti F, Mutch DG, Powell MA, Thaker PH, Siegel BA, Grigsby PW) Gynecol Oncol 2009 Jan;112(1):104-9 88 Citations |
1 | Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. (de la Fuente SG, Manson RJ, Ludwig KA, Mantyh CR) J Gastrointest Surg 2009 Feb;13(2):269-74 55 Citations |
1 | Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. (Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR) J Clin Oncol 2008 Nov 01;26(31):5043-51 834 Citations |
1 | Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):34-40 51 Citations |
1 | Hepatic neuroendocrine metastases: chemo- or bland embolization? (Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen H, Rilling WS, Quebbeman EJ, Agarwal DM, Pitt HA) J Gastrointest Surg 2008 Nov;12(11):1951-60 86 Citations |
1 | Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? (Pisters PW, Evans DB) Ann Surg 2008 Aug;248(2):152-3 4 Citations |
1 | Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. (Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA) J Clin Oncol 2008 Jul 20;26(21):3496-502 655 Citations |
1 | Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. (Braiteh F, Kurzrock R, Johnson FM) J Clin Oncol 2008 Jul 10;26(20):3460-2 37 Citations |
1 | Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. (Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF) J Am Coll Surg 2008 May;206(5):833-46; discussion 846-8 686 Citations |
1 | Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect. (Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Blum KA, Devine SM) Biol Blood Marrow Transplant 2008 Apr;14(4):480-3 34 Citations |
1 | Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides. (Cen P, Duvic M, Cohen PR, Kurzrock R) J Am Acad Dermatol 2008 Mar;58(3):382-6 5 Citations |
1 | Tumor-node-metastasis staging of pancreatic adenocarcinoma. (Katz MH, Hwang R, Fleming JB, Evans DB) CA Cancer J Clin 2008;58(2):111-25 101 Citations |
1 | External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. (Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED) Cancer 2008 Apr 01;112(7):1471-9 116 Citations |
1 | Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer. (Nguyen TT, Wright JD, Powell MA, Gibb RK, Rader JS, Allsworth JE, Mutch DG) Int J Gynecol Cancer 2008;18(6):1194-9 13 Citations |
1 | Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. (Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI) Head Neck 2008 Jul;30(7):883-8 72 Citations |
1 | Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer. (Tierney RM, Powell MA, Mutch DG, Gibb RK, Rader JS, Grigsby PW) Radiat Med 2007 Nov;25(9):439-45 15 Citations |
1 | [New developments in staging and prognosis of bronchopulmonary carcinoma. Part I: Epidemiology and diagnostic investigations]. (Ioachimescu O, Corlan E) Pneumologia 2007;56(3):129-36 |
1 | Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. (Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, Lodge JP) Eur J Surg Oncol 2008 Feb;34(2):180-4 5 Citations |
1 | Colon cancer. (Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP, Fox Chase Cancer Center Partners) J Natl Compr Canc Netw 2007 Oct;5(9):884-925 10 Citations |
1 | Endometrial carcinoma expresses an increased cathepsin B/D ratio. (Bradley WH, Lima PH, Rodgers L, Blomquist CH, Downs LS) Gynecol Oncol 2008 Jan;108(1):84-9 8 Citations |
1 | Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. (Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):735-43 66 Citations |
1 | Rectal cancer. (Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2007 Oct;5(9):940-81 8 Citations |
1 | Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. (Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED) J Clin Oncol 2007 Oct 20;25(30):4757-64 158 Citations |
1 | Population-based study of islet cell carcinoma. (Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB) Ann Surg Oncol 2007 Dec;14(12):3492-500 271 Citations |
1 | Multiple myeloma: charging toward a bright future. (Katzel JA, Hari P, Vesole DH) CA Cancer J Clin 2007;57(5):301-18 91 Citations |
1 | Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. (Gusani NJ, Balaa FK, Steel JL, Geller DA, Marsh JW, Zajko AB, Carr BI, Gamblin TC) J Gastrointest Surg 2008 Jan;12(1):129-37 113 Citations |
1 | Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Tward JD, Skidmore TB, Gaffney DK) Cancer 2007 Nov 01;110(9):2092-100 29 Citations |
1 | Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer. (Wright JD, Grigsby PW, Rader JS, Mutch DG, Powell MA, Gao F, Gibb RK) Gynecol Oncol 2007 Nov;107(2):280-4 3 Citations |
1 | A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. (Wright JD, Secord AA, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Gibb RK, Trinkaus K, Rader JS, Mutch DG) Int J Gynecol Cancer 2008;18(3):400-6 36 Citations |
1 | Adrenal cortical carcinoma--review of current knowledge and treatment practices. (Phan AT) Hematol Oncol Clin North Am 2007 Jun;21(3):489-507; viii-ix 37 Citations |
1 | Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study. (Ehrlich PF, Friedman DL, Schwartz CL, Children Oncology Group Hodgkin Lymphoma study section) J Pediatr Surg 2007 May;42(5):788-91 14 Citations |
1 | Rectourethral fistula after combination radiotherapy for prostate cancer. (Marguet C, Raj GV, Brashears JH, Anscher MS, Ludwig K, Mouraviev V, Robertson CN, Polascik TJ) Urology 2007 May;69(5):898-901 42 Citations |
1 | External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. (Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW) Gynecol Oncol 2007 Jul;106(1):215-20 45 Citations |
1 | Surgical patterns of care in operable lung carcinoma treated with radiation. (Chang JY, Moughan J, Johnstone DW, Komaki R, Goldberg M, Langer CJ, Beadle BM, Owen J, Movsas B) J Thorac Oncol 2006 Jul;1(6):526-31 4 Citations |
1 | Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. (Qi CF, Zhou JX, Lee CH, Naghashfar Z, Xiang S, Kovalchuk AL, Fredrickson TN, Hartley JW, Roopenian DC, Davidson WF, Janz S, Morse HC 3rd) Cancer Res 2007 Mar 15;67(6):2439-47 23 Citations |
1 | Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. (Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, Prasad KR) Eur J Surg Oncol 2007 Oct;33(8):1003-9 61 Citations |
1 | A multi-institutional review of outcomes of endometrial stromal sarcoma. (Leath CA 3rd, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA) Gynecol Oncol 2007 Jun;105(3):630-4 171 Citations |
1 | Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. (Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL) J Clin Oncol 2007 Feb 10;25(5):493-500 401 Citations |
4 | Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. (Gilligan MA, Neuner J, Zhang X, Sparapani R, Laud PW, Nattinger AB) Am J Public Health 2007 Mar;97(3):539-44 49 Citations |
1 | Adrenocortical carcinoma. (Rodgers SE, Evans DB, Lee JE, Perrier ND) Surg Oncol Clin N Am 2006 Jul;15(3):535-53 24 Citations |
1 | Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. (Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA) Ann Surg Oncol 2006 Aug;13(8):1035-46 738 Citations |
1 | POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. (Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR, Children's Oncology Group) J Pediatr Hematol Oncol 2006 Jun;28(6):362-8 79 Citations |
1 | Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study. (Tsimberidou AM, Keating MJ, Bueso-Ramos CE, Kurzrock R) Leuk Lymphoma 2006 May;47(5):827-36 36 Citations |
1 | Gene expression patterns in advanced human cervical cancer. (Grigsby PW, Watson M, Powell MA, Zhang Z, Rader JS) Int J Gynecol Cancer 2006;16(2):562-7 27 Citations |
1 | Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer. (Wright JD, Viviano D, Powell MA, Gibb RK, Mutch DG, Grigsby PW, Rader JS) Gynecol Oncol 2006 Nov;103(2):489-93 99 Citations |
1 | Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. (Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL) Cancer Res 2006 Mar 15;66(6):3323-30 73 Citations |
1 | Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA) J Clin Oncol 2006 Mar 01;24(7):1145-51 197 Citations |
1 | Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdom Imaging 2006;31(5):568-74 61 Citations |
1 | Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. (Czito BG, Willett CG, Bendell JC, Morse MA, Tyler DS, Fernando NH, Mantyh CR, Blobe GC, Honeycutt W, Yu D, Clary BM, Pappas TN, Ludwig KA, Hurwitz HI) J Clin Oncol 2006 Feb 01;24(4):656-62 130 Citations |
1 | Large plantar mass in a newborn. (Galbraith SS, King DM, Drolet BA, Esterly NB) Pediatr Dermatol 2006;23(1):84-6 2 Citations |
1 | Preoperative chemoradiation for pancreatic cancer. (Evans DB) Semin Oncol 2005 Dec;32(6 Suppl 9):S25-9 13 Citations |
1 | Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. (Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, Chen H, Liu DH, Gao ZY, Chen YH, Xu LP, Zhang YC, Ren HY, Li D, Liu KY) Blood 2006 Apr 15;107(8):3065-73 442 Citations |
1 | Refractory Hodgkin lymphoma responds to pentostatin (2'-deoxycoformycin). (Braiteh F, Ng C, Kurzrock R) Leuk Lymphoma 2006 Feb;47(2):373-5 5 Citations |
1 | Downstaging hepatocellular carcinoma prior to liver transplantation. (Gamblin TC, Geller DA) Liver Transpl 2005 Dec;11(12):1466-8 13 Citations |
1 | Value of laparoscopy in the staging of pancreatic cancer. (Camacho D, Reichenbach D, Duerr GD, Venema TL, Sweeney JF, Fisher WE) JOP 2005 Nov 10;6(6):552-61 38 Citations |
1 | Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. (Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, Gibb RK, Powell MA, Gao F, Siegel BA, Grigsby PW) Cancer 2005 Dec 01;104(11):2484-91 156 Citations |
1 | Relationship of ovarian neoplasms and body mass index. (Wright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Gao F, Herzog TJ) J Reprod Med 2005 Aug;50(8):595-602 9 Citations |
1 | Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. (Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman LD) Gynecol Oncol 2006 Feb;100(2):288-93 52 Citations |
1 | American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. (Small W Jr, Erickson B, Kwakwa F) Int J Radiat Oncol Biol Phys 2005 Dec 01;63(5):1502-7 85 Citations |
1 | Rectal cancer clinical practice guidelines in oncology. (Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2005 Jul;3(4):492-508 21 Citations |
1 | Colon cancer clinical practice guidelines in oncology. (Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2005 Jul;3(4):468-91 58 Citations |
1 | Anal canal cancer clinical practice guidelines in oncology. (Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2005 Jul;3(4):510-5 12 Citations |
2 | Creation of a quality of life instrument for nonmelanoma skin cancer patients. (Rhee JS, Matthews BA, Neuburg M, Burzynski M, Nattinger AB) Laryngoscope 2005 Jul;115(7):1178-85 58 Citations |
1 | Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database. (Langenstroer P, Carroll P, Thrasher JB) J Urol 2005 Jul;174(1):118-20 5 Citations |
1 | FDG-PET evaluation of vaginal carcinoma. (Lamoreaux WT, Grigsby PW, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA) Int J Radiat Oncol Biol Phys 2005 Jul 01;62(3):733-7 87 Citations |
1 | Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. (Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Radiation Therapy Oncology Group) J Clin Oncol 2005 May 20;23(15):3480-7 115 Citations |
1 | Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma. (Wright JD, Li J, Gerhard DS, Zhang Z, Huettner PC, Powell MA, Gibb RK, Herzog TJ, Mutch DG, Trinkaus KM, Rader JS) Gynecol Oncol 2005 Jul;98(1):84-91 23 Citations |
1 | Combined-modality treatment for operable pancreatic adenocarcinoma. (Pisters PW, Wolff RA, Crane CH, Evans DB) Oncology (Williston Park) 2005 Mar;19(3):393-404, 409; discussion 409-10, 412-6 24 Citations |
1 | Celecoxib and radiation therapy in non-small-cell lung cancer. (Gore E) Oncology (Williston Park) 2004 Dec;18(14 Suppl 14):10-4 23 Citations |
1 | Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. (Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS) Genes Chromosomes Cancer 2005 May;43(1):95-103 14 Citations |
1 | Radio-frequency ablation of large, nonresectable hepatic tumors. (Morgan JH 3rd, Royer GM, Hackett P, Gamblin TC, McCampbell BL, Conforti A, Dale PS) Am Surg 2004 Dec;70(12):1035-8 6 Citations |
1 | Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. (Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB) Surgery 2004 Dec;136(6):1183-91 84 Citations |
1 | Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. (Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG) Gynecol Oncol 2004 Dec;95(3):546-51 134 Citations |
1 | Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. (Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC) J Clin Oncol 2004 Dec 01;22(23):4762-71 509 Citations |
1 | A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? (Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS) Gynecol Oncol 2004 Oct;95(1):70-6 54 Citations |
1 | Neoadjuvant therapy for resectable pancreatic cancer. (Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA) Surg Oncol Clin N Am 2004 Oct;13(4):639-61, ix 53 Citations |
1 | Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms. (Wright JD, Powell MA, Herzog TJ, Mutch DG, Rader JS, Gao F, Gibb RK) Gynecol Oncol 2004 Aug;94(2):436-41 21 Citations |
1 | Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? (Kamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS) Gynecol Oncol 2004 Aug;94(2):249-55 31 Citations |
1 | Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas. (Tsimberidou AM, Giles FJ, Duvic M, Kurzrock R) J Am Acad Dermatol 2004 Aug;51(2):200-4 27 Citations |
1 | Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. (Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E) J Clin Oncol 2004 Jul 15;22(14):2856-64 165 Citations |
1 | Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. (Lentz SE, Muderspach LI, Felix JC, Ye W, Groshen S, Amezcua CA) Obstet Gynecol 2004 Jun;103(6):1204-10 84 Citations |
1 | Gastric carcinoma. (Phan AT, Ajani JA) Curr Oncol Rep 2004 May;6(3):192-8 9 Citations |
1 | Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. (Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM) Cancer 2004 Mar 01;100(5):942-9 48 Citations |
1 | A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. (Czito BG, Hong TJ, Cohen DP, Tyler DS, Lee CG, Anscher MS, Ludwig KA, Seigler HF, Mantyh C, Morse MA, Lockhart AC, Petros WP, Honeycutt W, Spector NL, Ertel PJ, Mangum SG, Hurwitz HI) Int J Radiat Oncol Biol Phys 2004 Mar 01;58(3):779-85 7 Citations |
1 | Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies. (Tsimberidou AM, Giles F, Romaguera J, Duvic M, Kurzrock R) Cancer 2004 Feb 01;100(3):574-80 21 Citations |
1 | Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. (Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB) Surgery 2003 Dec;134(6):946-54; discussion 954-5 430 Citations |
2 | Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. (Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB) Surgery 2003 Dec;134(6):890-9; discussion 899-901 71 Citations |
1 | Radiotherapy patterns of care study in lung carcinoma. (Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J) J Clin Oncol 2003 Dec 15;21(24):4553-9 92 Citations |
2 | High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. (Firat S, Murray K, Erickson B) Int J Radiat Oncol Biol Phys 2003 Sep 01;57(1):201-7 40 Citations |
1 | Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. (Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R) J Am Acad Dermatol 2003 Jul;49(1):35-49 64 Citations |
1 | Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. (Uyar DS, Eltabbakh GH, Mount SL) Gynecol Oncol 2003 May;89(2):227-32 24 Citations |
1 | Diagnosis, staging, and surveillance of pancreatic cancer. (Tamm EP, Silverman PM, Charnsangavej C, Evans DB) AJR Am J Roentgenol 2003 May;180(5):1311-23 77 Citations |
1 | A phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck. (Regine WF, Valentino J, Arnold SM, Sloan D, Kenady D, Strottmann J, Mohiuddin M) Technol Cancer Res Treat 2002 Apr;1(2):133-40 2 Citations |
1 | Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. (Crane CH, Antolak JA, Rosen II, Forster KM, Evans DB, Janjan NA, Charnsangavej C, Pisters PW, Lenzi R, Papagikos MA, Wolff RA) Int J Gastrointest Cancer 2001;30(3):123-32 57 Citations |
1 | Subaquatic laparoscopy for staging of intraabdominal malignancy. (Abdalla EK, Barnett CC, Pisters PW, Cleary KR, Evans DB, Feig BW, Mansfield PF) J Am Coll Surg 2003 Jan;196(1):155-8 5 Citations |
1 | Phase I study of rubitecan and gemcitabine in patients with advanced malignancies. (Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL) Ann Oncol 2002 Nov;13(11):1819-25 7 Citations |
1 | Ejaculatory function in stage T1 nonseminomatous germ cell tumors: retroperitoneal lymph node dissection versus surveillance--a decision analysis. (Langenstroer P, Rosen MA, Griebling TL, Thrasher JB) J Urol 2002 Oct;168(4 Pt 1):1396-401 5 Citations |
2 | Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2002 Oct 01;54(2):357-64 180 Citations |
1 | The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. (Ferrajoli A, Keating MJ, Manshouri T, Giles FJ, Dey A, Estrov Z, Koller CA, Kurzrock R, Thomas DA, Faderl S, Lerner S, O'Brien S, Albitar M) Blood 2002 Aug 15;100(4):1215-9 169 Citations |
1 | Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. (Powell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH, Goodfellow PJ) Cancer 2002 Jun 01;94(11):2941-52 52 Citations |
1 | Swallow function and perception of dysphagia in patients with head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L) Head Neck 2002 Jun;24(6):555-65 138 Citations |
1 | The role of a second transurethral resection for high-grade bladder cancer. (Langenstroer P, See W) Curr Urol Rep 2000 Oct;1(3):204-7 7 Citations |
1 | Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. (Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB) J Clin Oncol 2002 May 15;20(10):2537-44 186 Citations |
1 | Survival of women after breast conserving surgery for early stage breast cancer. (Du Xianglin, Freeman JL, Nattinger AB, Goodwin JS) Breast Cancer Res Treat 2002 Mar;72(1):23-31 32 Citations |
2 | Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. (Firat S, Bousamra M, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):1047-57 174 Citations |
1 | Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. (Cohn DE, Dehdashti F, Gibb RK, Mutch DG, Rader JS, Siegel BA, Herzog TJ) Gynecol Oncol 2002 Apr;85(1):179-84 153 Citations |
1 | Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. (Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB) Oncologist 2002;7(1):34-45 80 Citations |
1 | Epithelial ovarian tumors of low malignant potential: the role of microinvasion. (Buttin BM, Herzog TJ, Powell MA, Rader JS, Mutch DG) Obstet Gynecol 2002 Jan;99(1):11-7 66 Citations |
1 | The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Chao C, Erickson B, Fowler J, Gupta N, Martinez A, Thomadsen B, American Brachytherapy Society) Int J Radiat Oncol Biol Phys 2002 Jan 01;52(1):33-48 122 Citations |
1 | Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. (Karan D, Johansson SL, Lin MF, Batra SK) Oncol Rep 2001;8(5):1123-6 5 Citations |
1 | Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. (Evans DB) J Gastrointest Surg 2001;5(1):2-5 18 Citations |
1 | Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. (Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F) Oncogene 2001 Mar 22;20(12):1509-18 369 Citations |
1 | Ablation of liver metastasis: is preoperative imaging sufficiently accurate? (Wallace JR, Christians KK, Quiroz FA, Foley WD, Pitt HA, Quebbeman EJ) J Gastrointest Surg 2001;5(1):98-107 34 Citations |
1 | Laparoscopy in the staging of pancreatic cancer. (Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB) Br J Surg 2001 Mar;88(3):325-37 214 Citations |
1 | Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. (Grigsby PW, Perez CA, Chao KS, Herzog T, Mutch DG, Rader J) Int J Radiat Oncol Biol Phys 2001 Mar 01;49(3):733-8 60 Citations |
2 | Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. (Firat S, Erickson B) Gynecol Oncol 2001 Feb;80(2):213-20 28 Citations |
1 | Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. (Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S, Kurzrock R) Blood 2001 Jan 01;97(1):256-63 250 Citations |
1 | Clinical significance of microsatellite instability in endometrial carcinoma. (Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ) Cancer 2000 Oct 15;89(8):1758-64 112 Citations |
1 | De novo CD5+ diffuse large B-cell lymphomas. A heterogeneous group containing an unusual form of splenic lymphoma. (Kroft SH, Howard MS, Picker LJ, Ansari MQ, Aquino DB, McKenna RW) Am J Clin Pathol 2000 Oct;114(4):523-33 47 Citations |
1 | High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. (Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM) Ann Intern Med 2000 Oct 03;133(7):504-15 48 Citations |
1 | The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D) Int J Radiat Oncol Biol Phys 2000 Aug 01;48(1):201-11 406 Citations |
1 | Pretreatment swallowing function in patients with head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Stein D, Beery Q, Newman L, Hanchett C, Tusant S, MacCracken E) Head Neck 2000 Aug;22(5):474-82 134 Citations |
1 | Thyroid cancer: 1999 update. (Tyler DS, Shaha AR, Udelsman RA, Sherman SI, Thompson NW, Moley JF, Evans DB) Ann Surg Oncol 2000 Jun;7(5):376-98 44 Citations |
2 | Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). (Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A) Blood 2000 Jun 15;95(12):3702-9 461 Citations |
1 | Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations. (Kovalchuk AL, Mushinski EB, Janz S) Leukemia 2000 May;14(5):909-21 18 Citations |
2 | Underutilization of mammography in older breast cancer survivors. (Schapira MM, McAuliffe TL, Nattinger AB) Med Care 2000 Mar;38(3):281-9 89 Citations |
1 | Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. (Zheng W, Lu JJ, Luo F, Zheng Y, Feng Yj, Felix JC, Lauchlan SC, Pike MC) Gynecol Oncol 2000 Jan;76(1):80-8 136 Citations |
1 | Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11 91 Citations |
1 | Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery. (Grigsby PW, Perez CA, Chao KS, Elbendary A, Herzog TJ, Rader JS, Mutch DG) Int J Radiat Oncol Biol Phys 1999 Oct 01;45(3):645-51 23 Citations |
1 | Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. (Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F) Cancer Res 1999 Sep 15;59(18):4662-7 55 Citations |
1 | Subglottic carcinoma: review of a series and characterization of its patterns of spread. (Strome SE, Robey TC, Devaney KO, Krause CJ, Hogikyan ND) Ear Nose Throat J 1999 Aug;78(8):622-4, 626, 628, passim 24 Citations |
1 | Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. (Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB) J Gastrointest Surg 1999;3(3):263-77 45 Citations |
1 | Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman K) Bone Marrow Transplant 1999 Aug;24(4):365-8 9 Citations |
1 | Screening for cancers of the head and neck: addressing the problem. (Ellison MD, Campbell BH) Surg Oncol Clin N Am 1999 Oct;8(4):725-34, vii 6 Citations |
1 | Staging laparoscopy: a peek may save a cut. (Saeian K, Reddy KR) Endoscopy 1999 Jun;31(5):389-91 7 Citations |
1 | Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. (Sian KU, Wagner JD, Sood R, Park HM, Havlik R, Coleman JJ) Ann Plast Surg 1999 Jun;42(6):679-82 42 Citations |
1 | Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Breslin TM, Janjan NA, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Evans DB) Front Biosci 1998 Nov 01;3:E193-203 20 Citations |
1 | Allogeneic bone marrow transplantation for low-grade lymphoma. (van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy PL Jr, Raemaekers JM, Reiffers J, Phillips GL, Schattenberg AV, Verdonck LF, Vose JM, Horowitz MM) Blood 1998 Sep 01;92(5):1832-6 240 Citations |
1 | Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression. (Somers LJ, Shaw B, Lyn BE, McMillan AM, Mahendra P) Clin Lab Haematol 1998 Jun;20(3):189-90 5 Citations |
1 | Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. (Roman LD, Felix JC, Muderspach LI, Varkey T, Burnett AF, Qian D, Morrow CP) Gynecol Oncol 1998 Mar;68(3):220-5 81 Citations |
1 | Primary pancreatic lymphoma. (Bouvet M, Staerkel GA, Spitz FR, Curley SA, Charnsangavej C, Hagemeister FB, Janjan NA, Pisters PW, Evans DB) Surgery 1998 Apr;123(4):382-90 44 Citations |
2 | Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. (Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ) Head Neck 1998 Mar;20(2):132-7 99 Citations |
1 | Estrogen-progestin replacement therapy and endometrial cancer. (Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM) J Natl Cancer Inst 1997 Aug 06;89(15):1110-6 288 Citations |
1 | Gastric cancer surgical practice guidelines. Gastric Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1067-72 3 Citations |
1 | Pancreatic cancer surgical practice guidelines. Pancreatic Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1074-9 6 Citations |
1 | Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. (Muderspach LI, Curtin JP, Roman LD, Gebhardt JA, Klement V, Qian D, Morrow CP, Felix JC, Formenti SC, Muggia FM) Gynecol Oncol 1997 May;65(2):336-42 45 Citations |
1 | Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors. (Lee JE, Evans DB) Cancer Treat Res 1997;90:227-38 5 Citations |
1 | Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. (Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F, Kurzrock R) Am J Med 1997 Jan;102(1):21-8 76 Citations |
1 | NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. (O'Reilly R, Link M, Fletcher B, Gebhardt M, Krance R, Meyers P, Neff J, Schwartz C) Oncology (Williston Park) 1996 Dec;10(12):1799-806, 1812 7 Citations |
1 | Mycosis fungoides and Sezary syndrome. (Diamandidou E, Cohen PR, Kurzrock R) Blood 1996 Oct 01;88(7):2385-409 257 Citations |
1 | Combined modality therapy for cutaneous T-cell lymphoma. (Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R) J Am Acad Dermatol 1996 Jun;34(6):1022-9 80 Citations |
1 | The need for standardized pathologic staging of pancreaticoduodenectomy specimens. (Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, Evans DB) Pancreas 1996 May;12(4):373-80 104 Citations |
1 | T stage and functional outcome in oral and oropharyngeal cancer patients. (Colangelo LA, Logemann JA, Pauloski BR, Pelzer JR, Rademaker AW) Head Neck 1996;18(3):259-68 54 Citations |
1 | Stage I and II Hodgkin's disease in the pediatric population. Long-term follow-up of patients staged predominantly clinically. (Rock DB, Murray KJ, Schultz CJ, Lauer SJ, Wilson JF) Am J Clin Oncol 1996 Apr;19(2):174-8 5 Citations |
1 | Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. (Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB) Surgery 1995 Dec;118(6):1090-8 102 Citations |
1 | X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. (Park TW, Felix JC, Wright TC Jr) Cancer Res 1995 Nov 01;55(21):4793-6 29 Citations |
1 | Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. (Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M) Int J Radiat Oncol Biol Phys 1995 Feb 15;31(4):743-51 15 Citations |
1 | Spinal magnetic resonance imaging immediately after craniotomy for detection of metastatic disease. (Kaufman BA, Moran CJ, Park TS) Pediatr Neurosurg 1995;23(4):171-81 5 Citations |
1 | Update on Hodgkin's disease. (Erickson JM) Nurse Pract 1994 Nov;19(11):63-8 |
1 | Chondrosarcoma of the jugular foramen. (Harvey SA, Wiet RJ, Kazan R) Am J Otol 1994 Mar;15(2):257-63 20 Citations |
1 | Continuous split course irradiation for stage I and II Hodgkin's disease: 20 year experience at the Medical College of Wisconsin. (Rock DB, Schultz CJ, Murray KJ, Wilson JF, Cox JD) Radiother Oncol 1994 Mar;30(3):222-6 6 Citations |
1 | Phase I trial of an oral immunomodulator and interferon inducer in cancer patients. (Witt PL, Ritch PS, Reding D, McAuliffe TL, Westrick L, Grossberg SE, Borden EC) Cancer Res 1993 Nov 01;53(21):5176-80 78 Citations |
1 | Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. (Jacobs JP, Murray KJ, Schultz CJ, Wilson JF, Goswitz MS, Stevens CW, Cox JD) J Clin Oncol 1993 Feb;11(2):233-8 68 Citations |
1 | Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC) Arch Surg 1992 Nov;127(11):1335-9 626 Citations |
1 | Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique. (Evans DB, Byrd DR, Mansfield PF) Am J Clin Oncol 1991 Aug;14(4):359-64 17 Citations |
1 | Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. (Leake JF, Rader JS, Woodruff JD, Rosenshein NB) Gynecol Oncol 1991 Aug;42(2):124-30 105 Citations |
1 | Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. (Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R) Cancer 1991 Feb 15;67(4):990-6 102 Citations |
1 | Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience. (Rader JS, Haraf DJ, Halpern HJ, Rotmensch J, Spelbring DR, Sutton H, Javaheri G, Weichselbaum RR) J Surg Oncol 1990 Jul;44(3):157-65 14 Citations |
1 | Role of the spleen in the transdiaphragmatic spread of Hodgkin's disease. (Mann JL, Hafez GR, Longo WL) Am J Med 1986 Dec;81(6):959-61 5 Citations |
1 | Diagnosis of malignant lymphomas of the nasal cavity, paranasal sinuses and nasopharynx. (Duncavage JA, Campbell BH, Hanson GA, Kun LE, Hansen RM, Toohill RJ, Malin TC) Laryngoscope 1983 Oct;93(10):1276-80 42 Citations |